{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T12:11:05Z","timestamp":1794485465123,"version":"4.9.1"},"reference-count":482,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-026-02920-0","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:01:21Z","timestamp":1786492881000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Innate immunity: current understandings and future perspectives"],"prefix":"10.1038","volume":"11","author":[{"given":"Chaoyu","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5173-0781","authenticated-orcid":false,"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6768-2382","authenticated-orcid":false,"given":"Xikun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"2920_CR1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41577-020-0391-5","volume":"21","author":"SR Paludan","year":"2021","unstructured":"Paludan, S. R., Pradeu, T., Masters, S. L. & Mogensen, T. H. Constitutive immune mechanisms: mediators of host defence and immune regulation. Nat. Rev. Immunol. 21, 137\u2013150 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"2920_CR2","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.immuni.2024.03.007","volume":"57","author":"T Pradeu","year":"2024","unstructured":"Pradeu, T., Thomma, B., Girardin, S. E. & Lemaitre, B. The conceptual foundations of innate immunity: taking stock 30 years later. Immunity 57, 613\u2013631 (2024).","journal-title":"Immunity"},{"key":"2920_CR3","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1016\/j.cell.2024.03.036","volume":"187","author":"S Carpenter","year":"2024","unstructured":"Carpenter, S. & O\u2019Neill, L. A. J. From periphery to center stage: 50 years of advancements in innate immunity. Cell 187, 2030\u20132051 (2024).","journal-title":"Cell"},{"key":"2920_CR4","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1038\/s12276-023-01022-z","volume":"55","author":"S Ryu","year":"2023","unstructured":"Ryu, S., Lim, M., Kim, J. & Kim, H. Y. Versatile roles of innate lymphoid cells at the mucosal barrier: from homeostasis to pathological inflammation. Exp. Mol. Med. 55, 1845\u20131857 (2023).","journal-title":"Exp. Mol. Med."},{"key":"2920_CR5","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41577-022-00732-1","volume":"23","author":"NK Wolf","year":"2023","unstructured":"Wolf, N. K., Kissiov, D. U. & Raulet, D. H. Roles of natural killer cells in immunity to cancer, and applications to immunotherapy. Nat. Rev. Immunol. 23, 90\u2013105 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"2920_CR6","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41392-024-02049-y","volume":"9","author":"F Zhang","year":"2024","unstructured":"Zhang, F. et al. Neutrophil diversity and function in health and disease. Signal Transduct. Target Ther. 9, 343 (2024).","journal-title":"Signal Transduct. Target Ther."},{"key":"2920_CR7","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/ni.3123","volume":"16","author":"A Iwasaki","year":"2015","unstructured":"Iwasaki, A. & Medzhitov, R. Control of adaptive immunity by the innate immune system. Nat. Immunol. 16, 343\u2013353 (2015).","journal-title":"Nat. Immunol."},{"key":"2920_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/SQB.1989.054.01.003","volume":"54 Pt 1","author":"CA Janeway Jr","year":"1989","unstructured":"Janeway, C. A. Jr Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 54 Pt 1, 1\u201313 (1989).","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"2920_CR9","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1146\/annurev.iy.12.040194.005015","volume":"12","author":"P Matzinger","year":"1994","unstructured":"Matzinger, P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12, 991\u20131045 (1994).","journal-title":"Annu. Rev. Immunol."},{"key":"2920_CR10","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/S0092-8674(00)80172-5","volume":"86","author":"B Lemaitre","year":"1996","unstructured":"Lemaitre, B. et al. The dorsoventral regulatory gene cassette spatzle\/Toll\/cactus controls the potent antifungal response in Drosophila adults. Cell 86, 973\u2013983 (1996).","journal-title":"Cell"},{"key":"2920_CR11","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1126\/science.282.5396.2085","volume":"282","author":"A Poltorak","year":"1998","unstructured":"Poltorak, A. et al. Defective LPS signaling in C3H\/HeJ and C57BL\/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085\u20132088 (1998).","journal-title":"Science"},{"key":"2920_CR12","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/41131","volume":"388","author":"R Medzhitov","year":"1997","unstructured":"Medzhitov, R., Preston-Hurlburt, P. & Janeway, C. A. Jr A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388, 394\u2013397 (1997).","journal-title":"Nature"},{"key":"2920_CR13","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1146\/annurev-immunol-081022-021207","volume":"41","author":"J Fu","year":"2023","unstructured":"Fu, J. & Wu, H. Structural mechanisms of NLRP3 inflammasome assembly and activation. Annu. Rev. Immunol. 41, 301\u2013316 (2023).","journal-title":"Annu. Rev. Immunol."},{"key":"2920_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41577-019-0215-7","volume":"20","author":"T Gong","year":"2020","unstructured":"Gong, T., Liu, L., Jiang, W. & Zhou, R. DAMP-sensing receptors in sterile inflammation and inflammatory diseases. Nat. Rev. Immunol. 20, 95\u2013112 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"2920_CR15","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","volume":"124","author":"S Akira","year":"2006","unstructured":"Akira, S., Uematsu, S. & Takeuchi, O. Pathogen recognition and innate immunity. Cell 124, 783\u2013801 (2006).","journal-title":"Cell"},{"key":"2920_CR16","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","volume":"140","author":"O Takeuchi","year":"2010","unstructured":"Takeuchi, O. & Akira, S. Pattern recognition receptors and inflammation. Cell 140, 805\u2013820 (2010).","journal-title":"Cell"},{"key":"2920_CR17","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.immuni.2024.03.004","volume":"57","author":"T Kawai","year":"2024","unstructured":"Kawai, T., Ikegawa, M., Ori, D. & Akira, S. Decoding Toll-like receptors: recent insights and perspectives in innate immunity. Immunity 57, 649\u2013673 (2024).","journal-title":"Immunity"},{"key":"2920_CR18","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0167-4781(00)00289-X","volume":"1518","author":"T Chuang","year":"2001","unstructured":"Chuang, T. & Ulevitch, R. J. Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells. Biochim. Biophys. Acta 1518, 157\u2013161 (2001).","journal-title":"Biochim. Biophys. Acta"},{"key":"2920_CR19","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/jlb.63.6.650","volume":"63","author":"LA O\u2019Neill","year":"1998","unstructured":"O\u2019Neill, L. A. & Greene, C. Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants. J. Leukoc. Biol. 63, 650\u2013657 (1998).","journal-title":"J. Leukoc. Biol."},{"key":"2920_CR20","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.dci.2011.03.006","volume":"35","author":"Y Palti","year":"2011","unstructured":"Palti, Y. Toll-like receptors in bony fish: from genomics to function. Dev. Comp. Immunol. 35, 1263\u20131272 (2011).","journal-title":"Dev. Comp. Immunol."},{"key":"2920_CR21","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1073\/pnas.95.2.588","volume":"95","author":"FL Rock","year":"1998","unstructured":"Rock, F. L. et al. A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. USA. 95, 588\u2013593 (1998).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2920_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-9-62","volume":"9","author":"ND Temperley","year":"2008","unstructured":"Temperley, N. D. et al. Evolution of the chicken Toll-like receptor gene family: a story of gene gain and gene loss. BMC Genom. 9, 62 (2008).","journal-title":"BMC Genom."},{"key":"2920_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.smim.2006.12.002","volume":"19","author":"K Miyake","year":"2007","unstructured":"Miyake, K. Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors. Semin. Immunol. 19, 3\u201310 (2007).","journal-title":"Semin. Immunol."},{"key":"2920_CR24","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/ni1569","volume":"9","author":"JC Kagan","year":"2008","unstructured":"Kagan, J. C. et al. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat. Immunol. 9, 361\u2013368 (2008).","journal-title":"Nat. Immunol."},{"key":"2920_CR25","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.cell.2008.02.043","volume":"133","author":"Y Imai","year":"2008","unstructured":"Imai, Y. et al. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 133, 235\u2013249 (2008).","journal-title":"Cell"},{"key":"2920_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.imlet.2009.05.006","volume":"125","author":"KM Lee","year":"2009","unstructured":"Lee, K. M. & Seong, S. Y. Partial role of TLR4 as a receptor responding to damage-associated molecular pattern. Immunol. Lett. 125, 31\u201339 (2009).","journal-title":"Immunol. Lett."},{"key":"2920_CR27","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/35074106","volume":"410","author":"F Hayashi","year":"2001","unstructured":"Hayashi, F. et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410, 1099\u20131103 (2001).","journal-title":"Nature"},{"key":"2920_CR28","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1086\/386289","volume":"189","author":"AT Gewirtz","year":"2004","unstructured":"Gewirtz, A. T. et al. Helicobacter pylori flagellin evades toll-like receptor 5-mediated innate immunity. J. Infect. Dis. 189, 1914\u20131920 (2004).","journal-title":"J. Infect. Dis."},{"key":"2920_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13506-6","volume":"10","author":"SK Pachathundikandi","year":"2019","unstructured":"Pachathundikandi, S. K. et al. T4SS-dependent TLR5 activation by Helicobacter pylori infection. Nat. Commun. 10, 5717 (2019).","journal-title":"Nat. Commun."},{"key":"2920_CR30","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.immuni.2024.03.005","volume":"57","author":"C Reis e Sousa","year":"2024","unstructured":"Reis e Sousa, C., Yamasaki, S. & Brown, G. D. Myeloid C-type lectin receptors in innate immune recognition. Immunity 57, 700\u2013717 (2024).","journal-title":"Immunity"},{"key":"2920_CR31","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1002\/eji.201847536","volume":"49","author":"K Tone","year":"2019","unstructured":"Tone, K., Stappers, M. H. T., Willment, J. A. & Brown, G. D. C-type lectin receptors of the Dectin-1 cluster: physiological roles and involvement in disease. Eur. J. Immunol. 49, 2127\u20132133 (2019).","journal-title":"Eur. J. Immunol."},{"key":"2920_CR32","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.immuni.2005.03.004","volume":"22","author":"NC Rogers","year":"2005","unstructured":"Rogers, N. C. et al. Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C-type lectins. Immunity 22, 507\u2013517 (2005).","journal-title":"Immunity"},{"key":"2920_CR33","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/35099560","volume":"413","author":"L Alexopoulou","year":"2001","unstructured":"Alexopoulou, L., Holt, A. C., Medzhitov, R. & Flavell, R. A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413, 732\u2013738 (2001).","journal-title":"Nature"},{"key":"2920_CR34","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1126\/science.1093616","volume":"303","author":"SS Diebold","year":"2004","unstructured":"Diebold, S. S. et al. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303, 1529\u20131531 (2004).","journal-title":"Science"},{"key":"2920_CR35","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1126\/science.1093620","volume":"303","author":"F Heil","year":"2004","unstructured":"Heil, F. et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303, 1526\u20131529 (2004).","journal-title":"Science"},{"key":"2920_CR36","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.15252\/embr.201540861","volume":"16","author":"A Kruger","year":"2015","unstructured":"Kruger, A. et al. Human TLR8 senses UR\/URR motifs in bacterial and mitochondrial RNA. EMBO Rep. 16, 1656\u20131663 (2015).","journal-title":"EMBO Rep."},{"key":"2920_CR37","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.immuni.2008.01.013","volume":"28","author":"T Haas","year":"2008","unstructured":"Haas, T. et al. The DNA sugar backbone 2\u2019 deoxyribose determines toll-like receptor 9 activation. Immunity 28, 315\u2013323 (2008).","journal-title":"Immunity"},{"key":"2920_CR38","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.chom.2009.12.003","volume":"7","author":"C Coban","year":"2010","unstructured":"Coban, C. et al. Immunogenicity of whole-parasite vaccines against Plasmodium falciparum involves malarial hemozoin and host TLR9. Cell Host Microbe 7, 50\u201361 (2010).","journal-title":"Cell Host Microbe"},{"key":"2920_CR39","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1073\/pnas.0608745104","volume":"104","author":"P Parroche","year":"2007","unstructured":"Parroche, P. et al. Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9. Proc. Natl. Acad. Sci. USA. 104, 1919\u20131924 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2920_CR40","doi-asserted-by":"publisher","first-page":"4818","DOI":"10.4049\/jimmunol.1301301","volume":"191","author":"M Raetz","year":"2013","unstructured":"Raetz, M. et al. Cooperation of TLR12 and TLR11 in the IRF8-dependent IL-12 response to Toxoplasma gondii profilin. J. Immunol. 191, 4818\u20134827 (2013).","journal-title":"J. Immunol."},{"key":"2920_CR41","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1126\/science.1109893","volume":"308","author":"F Yarovinsky","year":"2005","unstructured":"Yarovinsky, F. et al. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 308, 1626\u20131629 (2005).","journal-title":"Science"},{"key":"2920_CR42","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.4049\/jimmunol.1200898","volume":"189","author":"A Hidmark","year":"2012","unstructured":"Hidmark, A., von Saint Paul, A. & Dalpke, A. H. Cutting edge: TLR13 is a receptor for bacterial RNA. J. Immunol. 189, 2717\u20132721 (2012).","journal-title":"J. Immunol."},{"key":"2920_CR43","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1126\/science.1220363","volume":"337","author":"M Oldenburg","year":"2012","unstructured":"Oldenburg, M. et al. TLR13 recognizes bacterial 23S rRNA devoid of erythromycin resistance-forming modification. Science 337, 1111\u20131115 (2012).","journal-title":"Science"},{"key":"2920_CR44","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1126\/science.276.5313.726","volume":"276","author":"B Baker","year":"1997","unstructured":"Baker, B., Zambryski, P., Staskawicz, B. & Dinesh-Kumar, S. P. Signaling in plant-microbe interactions. Science 276, 726\u2013733 (1997).","journal-title":"Science"},{"key":"2920_CR45","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nri1708","volume":"5","author":"W Reith","year":"2005","unstructured":"Reith, W., LeibundGut-Landmann, S. & Waldburger, J. M. Regulation of MHC class II gene expression by the class II transactivator. Nat. Rev. Immunol. 5, 793\u2013806 (2005).","journal-title":"Nat. Rev. Immunol."},{"key":"2920_CR46","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.4049\/jimmunol.169.3.1326","volume":"169","author":"RK Pai","year":"2002","unstructured":"Pai, R. K., Askew, D., Boom, W. H. & Harding, C. V. Regulation of class II MHC expression in APCs: roles of types I, III, and IV class II transactivator. J. Immunol. 169, 1326\u20131333 (2002).","journal-title":"J. Immunol."},{"key":"2920_CR47","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1126\/science.8016643","volume":"265","author":"V Steimle","year":"1994","unstructured":"Steimle, V. et al. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science 265, 106\u2013109 (1994).","journal-title":"Science"},{"key":"2920_CR48","doi-asserted-by":"publisher","first-page":"14408","DOI":"10.1073\/pnas.1306376110","volume":"110","author":"J Yang","year":"2013","unstructured":"Yang, J., Zhao, Y., Shi, J. & Shao, F. Human NAIP and mouse NAIP1 recognize bacterial type III secretion needle protein for inflammasome activation. Proc. Natl. Acad. Sci. USA. 110, 14408\u201314413 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2920_CR49","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/nature10510","volume":"477","author":"Y Zhao","year":"2011","unstructured":"Zhao, Y. et al. The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature 477, 596\u2013600 (2011).","journal-title":"Nature"},{"key":"2920_CR50","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nature10394","volume":"477","author":"EM Kofoed","year":"2011","unstructured":"Kofoed, E. M. & Vance, R. E. Innate immune recognition of bacterial ligands by NAIPs determines inflammasome specificity. Nature 477, 592\u2013595 (2011).","journal-title":"Nature"},{"key":"2920_CR51","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/imr.12902","volume":"297","author":"BC Trindade","year":"2020","unstructured":"Trindade, B. C. & Chen, G. Y. NOD1 and NOD2 in inflammatory and infectious diseases. Immunol. Rev. 297, 139\u2013161 (2020).","journal-title":"Immunol. Rev."},{"key":"2920_CR52","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.trecan.2016.12.003","volume":"3","author":"S Yoshihama","year":"2017","unstructured":"Yoshihama, S., Vijayan, S., Sidiq, T. & Kobayashi, K. S. NLRC5\/CITA: a key player in cancer immune surveillance. Trends Cancer 3, 28\u201338 (2017).","journal-title":"Trends Cancer"},{"key":"2920_CR53","doi-asserted-by":"publisher","first-page":"26223","DOI":"10.1074\/jbc.M110.109736","volume":"285","author":"A Neerincx","year":"2010","unstructured":"Neerincx, A. et al. A role for the human nucleotide-binding domain, leucine-rich repeat-containing family member NLRC5 in antiviral responses. J. Biol. Chem. 285, 26223\u201326232 (2010).","journal-title":"J. Biol. Chem."},{"key":"2920_CR54","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.cell.2010.03.040","volume":"141","author":"J Cui","year":"2010","unstructured":"Cui, J. et al. NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways. Cell 141, 483\u2013496 (2010).","journal-title":"Cell"},{"key":"2920_CR55","doi-asserted-by":"publisher","first-page":"4061","DOI":"10.1016\/j.cell.2024.05.034","volume":"187","author":"B Sundaram","year":"2024","unstructured":"Sundaram, B. et al. NLRC5 senses NAD(+) depletion, forming a PANoptosome and driving PANoptosis and inflammation. Cell 187, 4061\u20134077 e4017 (2024).","journal-title":"Cell"},{"key":"2920_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11076-1","volume":"10","author":"F Hoss","year":"2019","unstructured":"Hoss, F. et al. Alternative splicing regulates stochastic NLRP3 activity. Nat. Commun. 10, 3238 (2019).","journal-title":"Nat. Commun."},{"key":"2920_CR57","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1146\/annurev-immunol-101320-011235","volume":"40","author":"K Nozaki","year":"2022","unstructured":"Nozaki, K., Li, L. & Miao, E. A. Innate sensors trigger regulated cell death to combat intracellular infection. Annu. Rev. Immunol. 40, 469\u2013498 (2022).","journal-title":"Annu. Rev. Immunol."},{"key":"2920_CR58","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.immuni.2011.03.026","volume":"34","author":"IC Allen","year":"2011","unstructured":"Allen, I. C. et al. NLRX1 protein attenuates inflammatory responses to infection by interfering with the RIG-I-MAVS and TRAF6-NF-kappaB signaling pathways. Immunity 34, 854\u2013865 (2011).","journal-title":"Immunity"},{"key":"2920_CR59","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/ni.3853","volume":"18","author":"H Feng","year":"2017","unstructured":"Feng, H. et al. NLRX1 promotes immediate IRF1-directed antiviral responses by limiting dsRNA-activated translational inhibition mediated by PKR. Nat. Immunol. 18, 1299\u20131309 (2017).","journal-title":"Nat. Immunol."},{"key":"2920_CR60","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.immuni.2012.03.025","volume":"36","author":"Y Lei","year":"2012","unstructured":"Lei, Y. et al. The mitochondrial proteins NLRX1 and TUFM form a complex that regulates type I interferon and autophagy. Immunity 36, 933\u2013946 (2012).","journal-title":"Immunity"},{"key":"2920_CR61","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nature06501","volume":"451","author":"CB Moore","year":"2008","unstructured":"Moore, C. B. et al. NLRX1 is a regulator of mitochondrial antiviral immunity. Nature 451, 573\u2013577 (2008).","journal-title":"Nature"},{"key":"2920_CR62","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41590-019-0324-2","volume":"20","author":"Y Zhang","year":"2019","unstructured":"Zhang, Y. et al. Listeria hijacks host mitophagy through a novel mitophagy receptor to evade killing. Nat. Immunol. 20, 433\u2013446 (2019).","journal-title":"Nat. Immunol."},{"key":"2920_CR63","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/s41577-020-0288-3","volume":"20","author":"J Rehwinkel","year":"2020","unstructured":"Rehwinkel, J. & Gack, M. U. RIG-I-like receptors: their regulation and roles in RNA sensing. Nat. Rev. Immunol. 20, 537\u2013551 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"2920_CR64","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.immuni.2011.05.003","volume":"34","author":"YM Loo","year":"2011","unstructured":"Loo, Y. M. & Gale, M. Jr Immune signaling by RIG-I-like receptors. Immunity 34, 680\u2013692 (2011).","journal-title":"Immunity"},{"key":"2920_CR65","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/nature06013","volume":"448","author":"A Takaoka","year":"2007","unstructured":"Takaoka, A. et al. DAI (DLM-1\/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448, 501\u2013505 (2007).","journal-title":"Nature"},{"key":"2920_CR66","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41586-018-0433-3","volume":"561","author":"P Zhou","year":"2018","unstructured":"Zhou, P. et al. Alpha-kinase 1 is a cytosolic innate immune receptor for bacterial ADP-heptose. Nature 561, 122\u2013126 (2018).","journal-title":"Nature"},{"key":"2920_CR67","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/nature09121","volume":"465","author":"SC Lin","year":"2010","unstructured":"Lin, S. C., Lo, Y. C. & Wu, H. Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR\/IL-1R signalling. Nature 465, 885\u2013890 (2010).","journal-title":"Nature"},{"key":"2920_CR68","doi-asserted-by":"publisher","first-page":"113944","DOI":"10.1016\/j.celrep.2024.113944","volume":"43","author":"M Brandt","year":"2024","unstructured":"Brandt, M. et al. Translational genetics identifies a phosphorylation switch in CARD9 required for innate inflammatory responses. Cell Rep. 43, 113944 (2024).","journal-title":"Cell Rep."},{"key":"2920_CR69","doi-asserted-by":"publisher","first-page":"E3403","DOI":"10.1073\/pnas.1603269113","volume":"113","author":"B Zhao","year":"2016","unstructured":"Zhao, B. et al. Structural basis for concerted recruitment and activation of IRF-3 by innate immune adaptor proteins. Proc. Natl. Acad. Sci. USA. 113, E3403\u2013E3412 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2920_CR70","doi-asserted-by":"publisher","DOI":"10.1126\/science.adl0429","volume":"386","author":"NS Gokhale","year":"2024","unstructured":"Gokhale, N. S. et al. Cellular RNA interacts with MAVS to promote antiviral signaling. Science 386, eadl0429 (2024).","journal-title":"Science"},{"key":"2920_CR71","doi-asserted-by":"publisher","DOI":"10.1172\/JCI177924","volume":"134","author":"L Wang","year":"2024","unstructured":"Wang, L. et al. Palmitoylation acts as a checkpoint for MAVS aggregation to promote antiviral innate immune responses. J. Clin. Investig. 134, e177924 (2024).","journal-title":"J. Clin. Investig."},{"key":"2920_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44317-5","volume":"15","author":"H Kemmoku","year":"2024","unstructured":"Kemmoku, H. et al. Single-molecule localization microscopy reveals STING clustering at the trans-Golgi network through palmitoylation-dependent accumulation of cholesterol. Nat. Commun. 15, 220 (2024).","journal-title":"Nat. Commun."},{"key":"2920_CR73","doi-asserted-by":"publisher","first-page":"14391","DOI":"10.1021\/acs.jmedchem.3c00593","volume":"66","author":"M Rivoal","year":"2023","unstructured":"Rivoal, M., Dubuquoy, L., Millet, R. & Leleu-Chavain, N. Receptor interacting Ser\/Thr-protein kinase 2 as a new therapeutic target. J. Med. Chem. 66, 14391\u201314410 (2023).","journal-title":"J. Med. Chem."},{"key":"2920_CR74","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s41586-022-05570-8","volume":"613","author":"L Xiao","year":"2023","unstructured":"Xiao, L., Magupalli, V. G. & Wu, H. Cryo-EM structures of the active NLRP3 inflammasome disc. Nature 613, 595\u2013600 (2023).","journal-title":"Nature"},{"key":"2920_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45396-8","volume":"15","author":"X Yu","year":"2024","unstructured":"Yu, X. et al. Structural basis for the oligomerization-facilitated NLRP3 activation. Nat. Commun. 15, 1164 (2024).","journal-title":"Nat. Commun."},{"key":"2920_CR76","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1016\/j.immuni.2022.10.021","volume":"55","author":"NA Schmacke","year":"2022","unstructured":"Schmacke, N. A. et al. IKKbeta primes inflammasome formation by recruiting NLRP3 to the trans-Golgi network. Immunity 55, 2271\u20132284 e2277 (2022).","journal-title":"Immunity"},{"key":"2920_CR77","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/nature15541","volume":"526","author":"N Kayagaki","year":"2015","unstructured":"Kayagaki, N. et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature 526, 666\u2013671 (2015).","journal-title":"Nature"},{"key":"2920_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16889-z","volume":"11","author":"JC Santos","year":"2020","unstructured":"Santos, J. C. et al. Human GBP1 binds LPS to initiate assembly of a caspase-4 activating platform on cytosolic bacteria. Nat. Commun. 11, 3276 (2020).","journal-title":"Nat. Commun."},{"key":"2920_CR79","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41586-023-06742-w","volume":"624","author":"X Shi","year":"2023","unstructured":"Shi, X. et al. Recognition and maturation of IL-18 by caspase-4 noncanonical inflammasome. Nature 624, 442\u2013450 (2023).","journal-title":"Nature"},{"key":"2920_CR80","doi-asserted-by":"publisher","first-page":"4419","DOI":"10.1038\/s44318-025-00507-z","volume":"44","author":"M Pizzuto","year":"2025","unstructured":"Pizzuto, M. et al. Cardiolipin inhibits the non-canonical inflammasome by preventing LPS binding to caspase-4\/11. EMBO J 44, 4419\u20134442 (2025).","journal-title":"EMBO J"},{"key":"2920_CR81","doi-asserted-by":"publisher","first-page":"101100","DOI":"10.1016\/j.mam.2022.101100","volume":"88","author":"O Paerewijck","year":"2022","unstructured":"Paerewijck, O. & Lamkanfi, M. The human inflammasomes. Mol. Aspects Med. 88, 101100 (2022).","journal-title":"Mol. Aspects Med."},{"key":"2920_CR82","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2016.58","volume":"16","author":"P Broz","year":"2016","unstructured":"Broz, P. & Dixit, V. M. Inflammasomes: mechanism of assembly, regulation and signalling. Nat. Rev. Immunol. 16, 407\u2013420 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"2920_CR83","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.immuni.2013.11.010","volume":"39","author":"C Garlanda","year":"2013","unstructured":"Garlanda, C., Dinarello, C. A. & Mantovani, A. The interleukin-1 family: back to the future. Immunity 39, 1003\u20131018 (2013).","journal-title":"Immunity"},{"key":"2920_CR84","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1146\/annurev-immunol-032713-120145","volume":"32","author":"JW Griffith","year":"2014","unstructured":"Griffith, J. W., Sokol, C. L. & Luster, A. D. Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu. Rev. Immunol. 32, 659\u2013702 (2014).","journal-title":"Annu. Rev. Immunol."},{"key":"2920_CR85","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41392-023-01542-0","volume":"8","author":"T Ma","year":"2023","unstructured":"Ma, T. et al. Chronic pulmonary bacterial infection facilitates breast cancer lung metastasis by recruiting tumor-promoting MHCII(hi) neutrophils. Signal Transduct. Target Ther. 8, 296 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"2920_CR86","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3389\/fimmu.2020.00483","volume":"11","author":"H Crijns","year":"2020","unstructured":"Crijns, H., Vanheule, V. & Proost, P. Targeting Chemokine-Glycosaminoglycan Interactions to Inhibit Inflammation. Front. Immunol. 11, 483 (2020).","journal-title":"Front. Immunol."},{"key":"2920_CR87","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/s41577-024-01025-5","volume":"24","author":"I Comerford","year":"2024","unstructured":"Comerford, I. & McColl, S. R. Atypical chemokine receptors in the immune system. Nat. Rev. Immunol. 24, 753\u2013769 (2024).","journal-title":"Nat. Rev. Immunol."},{"key":"2920_CR88","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41577-022-00694-4","volume":"22","author":"J Amersfoort","year":"2022","unstructured":"Amersfoort, J., Eelen, G. & Carmeliet, P. Immunomodulation by endothelial cells - partnering up with the immune system? Nat. Rev. Immunol. 22, 576\u2013588 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"2920_CR89","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/cr.2009.139","volume":"20","author":"JR Dunkelberger","year":"2010","unstructured":"Dunkelberger, J. R. & Song, W. C. Complement and its role in innate and adaptive immune responses. Cell Res. 20, 34\u201350 (2010).","journal-title":"Cell Res."},{"key":"2920_CR90","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41577-019-0168-x","volume":"19","author":"ES Reis","year":"2019","unstructured":"Reis, E. S., Mastellos, D. C., Hajishengallis, G. & Lambris, J. D. New insights into the immune functions of complement. Nat. Rev. Immunol. 19, 503\u2013516 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"2920_CR91","doi-asserted-by":"publisher","first-page":"4956","DOI":"10.1016\/j.cell.2023.09.020","volume":"186","author":"MK Yadav","year":"2023","unstructured":"Yadav, M. K. et al. Molecular basis of anaphylatoxin binding, activation, and signaling bias at complement receptors. Cell 186, 4956\u20134973.e4921 (2023).","journal-title":"Cell"},{"key":"2920_CR92","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/nchembio.2208","volume":"12","author":"J Maibaum","year":"2016","unstructured":"Maibaum, J. et al. Small-molecule factor D inhibitors targeting the alternative complement pathway. Nat. Chem. Biol. 12, 1105\u20131110 (2016).","journal-title":"Nat. Chem. Biol."},{"key":"2920_CR93","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nrd3011","volume":"9","author":"E Wagner","year":"2010","unstructured":"Wagner, E. & Frank, M. M. Therapeutic potential of complement modulation. Nat. Rev. Drug Discov. 9, 43\u201356 (2010).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2920_CR94","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.it.2010.01.002","volume":"31","author":"G Hajishengallis","year":"2010","unstructured":"Hajishengallis, G. & Lambris, J. D. Crosstalk pathways between Toll-like receptors and the complement system. Trends Immunol 31, 154\u2013163 (2010).","journal-title":"Trends Immunol"},{"key":"2920_CR95","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41581-023-00704-1","volume":"19","author":"EE West","year":"2023","unstructured":"West, E. E. & Kemper, C. Complosome - the intracellular complement system. Nat. Rev. Nephrol. 19, 426\u2013439 (2023).","journal-title":"Nat. Rev. Nephrol."},{"key":"2920_CR96","doi-asserted-by":"publisher","first-page":"102629","DOI":"10.1016\/j.coi.2025.102629","volume":"96","author":"V Baverel","year":"2025","unstructured":"Baverel, V., Garrido, C. & Kohli, E. Intracellular complement in monocytes and macrophages: emerging roles. Curr. Opin. Immunol. 96, 102629 (2025).","journal-title":"Curr. Opin. Immunol."},{"key":"2920_CR97","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abf2489","volume":"6","author":"N Niyonzima","year":"2021","unstructured":"Niyonzima, N. et al. Mitochondrial C5aR1 activity in macrophages controls IL-1beta production underlying sterile inflammation. Sci. Immunol. 6, eabf2489 (2021).","journal-title":"Sci. Immunol."},{"key":"2920_CR98","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.immuni.2020.02.006","volume":"52","author":"M Kolev","year":"2020","unstructured":"Kolev, M. et al. Diapedesis-induced integrin signaling via LFA-1 facilitates tissue immunity by inducing intrinsic complement C3 expression in immune cells. Immunity 52, 513\u2013527 e518 (2020).","journal-title":"Immunity"},{"key":"2920_CR99","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2484386","volume":"17","author":"CK Zhou","year":"2025","unstructured":"Zhou, C. K. et al. M28 family peptidase derived from Peribacillus frigoritolerans initiates trained immunity to prevent MRSA via the complosome-phosphatidylcholine axis. Gut Microbes 17, 2484386 (2025).","journal-title":"Gut Microbes"},{"key":"2920_CR100","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.it.2022.07.004","volume":"43","author":"D Capece","year":"2022","unstructured":"Capece, D. et al. NF-kappaB: blending metabolism, immunity, and inflammation. Trends Immunol. 43, 757\u2013775 (2022).","journal-title":"Trends Immunol."},{"key":"2920_CR101","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu, T., Zhang, L., Joo, D. & Sun, S. C. NF-kappaB signaling in inflammation. Signal Transduct. Target Ther. 2, 17023 (2017).","journal-title":"Signal Transduct. Target Ther."},{"key":"2920_CR102","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/ni.1857","volume":"11","author":"F Martinon","year":"2010","unstructured":"Martinon, F., Chen, X., Lee, A. H. & Glimcher, L. H. TLR activation of the transcription factor XBP1 regulates innate immune responses in macrophages. Nat. Immunol. 11, 411\u2013418 (2010).","journal-title":"Nat. Immunol."},{"key":"2920_CR103","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/nature05732","volume":"446","author":"MU Gack","year":"2007","unstructured":"Gack, M. U. et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446, 916\u2013920 (2007).","journal-title":"Nature"},{"key":"2920_CR104","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.chom.2010.11.008","volume":"8","author":"H Oshiumi","year":"2010","unstructured":"Oshiumi, H. et al. The ubiquitin ligase Riplet is essential for RIG-I-dependent innate immune responses to RNA virus infection. Cell Host Microbe 8, 496\u2013509 (2010).","journal-title":"Cell Host Microbe"},{"key":"2920_CR105","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.cell.2010.03.029","volume":"141","author":"W Zeng","year":"2010","unstructured":"Zeng, W. et al. Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell 141, 315\u2013330 (2010).","journal-title":"Cell"},{"key":"2920_CR106","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.cell.2011.06.041","volume":"146","author":"F Hou","year":"2011","unstructured":"Hou, F. et al. MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell 146, 448\u2013461 (2011).","journal-title":"Cell"},{"key":"2920_CR107","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa2630","volume":"347","author":"S Liu","year":"2015","unstructured":"Liu, S. et al. Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Science 347, aaa2630 (2015).","journal-title":"Science"},{"key":"2920_CR108","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1126\/science.1232458","volume":"339","author":"L Sun","year":"2013","unstructured":"Sun, L. et al. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339, 786\u2013791 (2013).","journal-title":"Science"},{"key":"2920_CR109","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11932","volume":"7","author":"K Mukai","year":"2016","unstructured":"Mukai, K. et al. Activation of STING requires palmitoylation at the Golgi. Nat. Commun. 7, 11932 (2016).","journal-title":"Nat. Commun."},{"key":"2920_CR110","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2100225118","volume":"118","author":"S Yum","year":"2021","unstructured":"Yum, S., Li, M., Fang, Y. & Chen, Z. J. TBK1 recruitment to STING activates both IRF3 and NF-kappaB that mediate immune defense against tumors and viral infections. Proc. Natl. Acad. Sci. USA. 118, e2100225118 (2021).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2920_CR111","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/imr.12198","volume":"261","author":"HS Li","year":"2014","unstructured":"Li, H. S. & Watowich, S. S. Innate immune regulation by STAT-mediated transcriptional mechanisms. Immunol. Rev. 261, 84\u2013101 (2014).","journal-title":"Immunol. Rev."},{"key":"2920_CR112","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4049\/jimmunol.1401867","volume":"194","author":"AV Villarino","year":"2015","unstructured":"Villarino, A. V., Kanno, Y., Ferdinand, J. R. & O\u2019Shea, J. J. Mechanisms of Jak\/STAT signaling in immunity and disease. J. Immunol. 194, 21\u201327 (2015).","journal-title":"J. Immunol."},{"key":"2920_CR113","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.immuni.2014.09.008","volume":"41","author":"A Palazon","year":"2014","unstructured":"Palazon, A., Goldrath, A. W., Nizet, V. & Johnson, R. S. HIF transcription factors, inflammation, and immunity. Immunity 41, 518\u2013528 (2014).","journal-title":"Immunity"},{"key":"2920_CR114","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.cmet.2020.08.002","volume":"32","author":"AF McGettrick","year":"2020","unstructured":"McGettrick, A. F. & O\u2019Neill, L. A. J. The role of HIF in immunity and inflammation. Cell Metab. 32, 524\u2013536 (2020).","journal-title":"Cell Metab."},{"key":"2920_CR115","doi-asserted-by":"publisher","first-page":"25660","DOI":"10.1074\/jbc.M804479200","volume":"283","author":"T Kubota","year":"2008","unstructured":"Kubota, T. et al. Virus infection triggers SUMOylation of IRF3 and IRF7, leading to the negative regulation of type I interferon gene expression. J. Biol. Chem. 283, 25660\u201325670 (2008).","journal-title":"J. Biol. Chem."},{"key":"2920_CR116","doi-asserted-by":"publisher","first-page":"6964","DOI":"10.1128\/MCB.25.16.6964-6979.2005","volume":"25","author":"G Bossis","year":"2005","unstructured":"Bossis, G. et al. Down-regulation of c-Fos\/c-Jun AP-1 dimer activity by sumoylation. Mol. Cell. Biol. 25, 6964\u20136979 (2005).","journal-title":"Mol. Cell. Biol."},{"key":"2920_CR117","doi-asserted-by":"publisher","first-page":"13321","DOI":"10.1074\/jbc.275.18.13321","volume":"275","author":"S Muller","year":"2000","unstructured":"Muller, S. et al. c-Jun and p53 activity is modulated by SUMO-1 modification. J. Biol. Chem. 275, 13321\u201313329 (2000).","journal-title":"J. Biol. Chem."},{"key":"2920_CR118","doi-asserted-by":"publisher","first-page":"6539","DOI":"10.1093\/emboj\/cdf660","volume":"21","author":"LF Chen","year":"2002","unstructured":"Chen, L. F., Mu, Y. & Greene, W. C. Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB. EMBO J. 21, 6539\u20136548 (2002).","journal-title":"EMBO J."},{"key":"2920_CR119","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1093\/nar\/gks916","volume":"41","author":"E Ziesche","year":"2013","unstructured":"Ziesche, E. et al. The coactivator role of histone deacetylase 3 in IL-1-signaling involves deacetylation of p65 NF-kappaB. Nucleic Acids Res. 41, 90\u2013109 (2013).","journal-title":"Nucleic Acids Res."},{"key":"2920_CR120","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/cmi.2011.59","volume":"9","author":"N Shembade","year":"2012","unstructured":"Shembade, N. & Harhaj, E. W. Regulation of NF-kappaB signaling by the A20 deubiquitinase. Cell. Mol. Immunol. 9, 123\u2013130 (2012).","journal-title":"Cell. Mol. Immunol."},{"key":"2920_CR121","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.immuni.2012.11.018","volume":"38","author":"E Wies","year":"2013","unstructured":"Wies, E. et al. Dephosphorylation of the RNA sensors RIG-I and MDA5 by the phosphatase PP1 is essential for innate immune signaling. Immunity 38, 437\u2013449 (2013).","journal-title":"Immunity"},{"key":"2920_CR122","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-020-00693-9","volume":"19","author":"V Lannoy","year":"2021","unstructured":"Lannoy, V., Cote-Biron, A., Asselin, C. & Rivard, N. Phosphatases in toll-like receptors signaling: the unfairly-forgotten. Cell Commun. Signal. 19, 10 (2021).","journal-title":"Cell Commun. Signal."},{"key":"2920_CR123","doi-asserted-by":"publisher","first-page":"113040","DOI":"10.1016\/j.celrep.2023.113040","volume":"42","author":"C Su","year":"2023","unstructured":"Su, C. et al. 4-Octyl itaconate restricts STING activation by blocking its palmitoylation. Cell Rep 42, 113040 (2023).","journal-title":"Cell Rep"},{"key":"2920_CR124","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s42255-022-00565-1","volume":"4","author":"W He","year":"2022","unstructured":"He, W. et al. Mesaconate is synthesized from itaconate and exerts immunomodulatory effects in macrophages. Nat. Metab. 4, 524\u2013533 (2022).","journal-title":"Nat. Metab."},{"key":"2920_CR125","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1038\/s41587-023-01957-8","volume":"42","author":"M Wang","year":"2024","unstructured":"Wang, M. et al. Killing tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responses. Nat. Biotechnol. 42, 1263\u20131274 (2024).","journal-title":"Nat. Biotechnol."},{"key":"2920_CR126","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1146\/annurev-immunol-093019-123619","volume":"39","author":"Q Zhang","year":"2021","unstructured":"Zhang, Q. & Cao, X. Epigenetic Remodeling in Innate Immunity and Inflammation. Annu. Rev. Immunol. 39, 279\u2013311 (2021).","journal-title":"Annu. Rev. Immunol."},{"key":"2920_CR127","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nri3777","volume":"15","author":"D \u00c1lvarez-Errico","year":"2015","unstructured":"\u00c1lvarez-Errico, D., Vento-Tormo, R., Sieweke, M. & Ballestar, E. Epigenetic control of myeloid cell differentiation, identity and function. Nat. Rev. Immunol. 15, 7\u201317 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"2920_CR128","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201798","volume":"218","author":"ZJ Gao","year":"2021","unstructured":"Gao, Z. J. et al. Single-nucleotide methylation specifically represses type I interferon in antiviral innate immunity. J. Exp. Med. 218, e20201798 (2021).","journal-title":"J. Exp. Med."},{"key":"2920_CR129","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1101\/gr.192005.115","volume":"25","author":"A Pacis","year":"2015","unstructured":"Pacis, A. et al. Bacterial infection remodels the DNA methylation landscape of human dendritic cells. Genome Res. 25, 1801\u20131811 (2015).","journal-title":"Genome Res."},{"key":"2920_CR130","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abn4002","volume":"8","author":"S Bannister","year":"2022","unstructured":"Bannister, S. et al. Neonatal BCG vaccination is associated with a long-term DNA methylation signature in circulating monocytes. Sci. Adv. 8, eabn4002 (2022).","journal-title":"Sci. Adv."},{"key":"2920_CR131","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1093\/molbev\/msaa084","volume":"37","author":"K Sagonas","year":"2020","unstructured":"Sagonas, K. et al. Experimental parasite infection causes genome-wide changes in DNA methylation. Mol. Biol. Evol. 37, 2287\u20132299 (2020).","journal-title":"Mol. Biol. Evol."},{"key":"2920_CR132","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.cmet.2020.11.016","volume":"33","author":"P Sadiku","year":"2021","unstructured":"Sadiku, P. et al. Neutrophils fuel effective immune responses through gluconeogenesis and glycogenesis. Cell Metab. 33, 411\u2013423.e414 (2021).","journal-title":"Cell Metab."},{"key":"2920_CR133","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41423-019-0315-0","volume":"17","author":"S Chen","year":"2020","unstructured":"Chen, S., Yang, J., Wei, Y. & Wei, X. Epigenetic regulation of macrophages: from homeostasis maintenance to host defense. Cell. Mol. Immunol. 17, 36\u201349 (2020).","journal-title":"Cell. Mol. Immunol."},{"key":"2920_CR134","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/eurheartj\/ehad787","volume":"45","author":"Z Dong","year":"2024","unstructured":"Dong, Z. et al. Myocardial infarction drives trained immunity of monocytes, accelerating atherosclerosis. Eur. Heart J. 45, 669\u2013684 (2024).","journal-title":"Eur. Heart J."},{"key":"2920_CR135","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1038\/ni.1920","volume":"11","author":"T Satoh","year":"2010","unstructured":"Satoh, T. et al. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat. Immunol. 11, 936\u2013944 (2010).","journal-title":"Nat. Immunol."},{"key":"2920_CR136","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.cell.2007.08.019","volume":"130","author":"F De Santa","year":"2007","unstructured":"De Santa, F. et al. The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell 130, 1083\u20131094 (2007).","journal-title":"Cell"},{"key":"2920_CR137","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13072-024-00562-6","volume":"17","author":"A Boonmee","year":"2024","unstructured":"Boonmee, A. et al. A polycomb group protein EED epigenetically regulates responses in lipopolysaccharide tolerized macrophages. Epigenet. Chromatin 17, 36 (2024).","journal-title":"Epigenet. Chromatin"},{"key":"2920_CR138","doi-asserted-by":"publisher","first-page":"4004","DOI":"10.1158\/1078-0432.CCR-16-2506","volume":"23","author":"TQ Tran","year":"2017","unstructured":"Tran, T. Q., Lowman, X. H. & Kong, M. Molecular pathways: metabolic control of histone methylation and gene expression in cancer. Clin. Cancer Res. 23, 4004\u20134009 (2017).","journal-title":"Clin. Cancer Res."},{"key":"2920_CR139","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/ni.3796","volume":"18","author":"PS Liu","year":"2017","unstructured":"Liu, P. S. et al. alpha-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming. Nat. Immunol. 18, 985\u2013994 (2017).","journal-title":"Nat. Immunol."},{"key":"2920_CR140","doi-asserted-by":"publisher","first-page":"110660","DOI":"10.1016\/j.celrep.2022.110660","volume":"39","author":"W Zhou","year":"2022","unstructured":"Zhou, W. et al. SENP1-Sirt3 signaling promotes alpha-ketoglutarate production during M2 macrophage polarization. Cell Rep. 39, 110660 (2022).","journal-title":"Cell Rep."},{"key":"2920_CR141","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1101\/gad.191056.112","volume":"26","author":"M Xiao","year":"2012","unstructured":"Xiao, M. et al. Inhibition of alpha-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev. 26, 1326\u20131338 (2012).","journal-title":"Genes Dev."},{"key":"2920_CR142","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.semcancer.2021.01.003","volume":"83","author":"S Ahmad","year":"2022","unstructured":"Ahmad, S. et al. Epigenetic underpinnings of inflammation: Connecting the dots between pulmonary diseases, lung cancer and COVID-19. Semin. Cancer Biol. 83, 384\u2013398 (2022).","journal-title":"Semin. Cancer Biol."},{"key":"2920_CR143","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.immuni.2013.08.009","volume":"39","author":"Y Qiao","year":"2013","unstructured":"Qiao, Y. et al. Synergistic activation of inflammatory cytokine genes by interferon-\u03b3-induced chromatin remodeling and toll-like receptor signaling. Immunity 39, 454\u2013469 (2013).","journal-title":"Immunity"},{"key":"2920_CR144","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.cell.2020.08.051","volume":"183","author":"EJ Giamarellos-Bourboulis","year":"2020","unstructured":"Giamarellos-Bourboulis, E. J. et al. Activate: randomized clinical trial of BCG vaccination against infection in the elderly. Cell 183, 315\u2013323 e319 (2020).","journal-title":"Cell"},{"key":"2920_CR145","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","volume":"23","author":"RJW Arts","year":"2018","unstructured":"Arts, R. J. W. et al. BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity. Cell Host Microbe 23, 89\u2013100 e105 (2018).","journal-title":"Cell Host Microbe"},{"key":"2920_CR146","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/j.immuni.2021.05.017","volume":"54","author":"BE Jugder","year":"2021","unstructured":"Jugder, B. E., Kamareddine, L. & Watnick, P. I. Microbiota-derived acetate activates intestinal innate immunity via the Tip60 histone acetyltransferase complex. Immunity 54, 1683\u20131697.e1683 (2021).","journal-title":"Immunity"},{"key":"2920_CR147","doi-asserted-by":"publisher","DOI":"10.34133\/research.0365","volume":"7","author":"S Shrestha","year":"2024","unstructured":"Shrestha, S. et al. Diabetes primes neutrophils for neutrophil extracellular trap formation through trained immunity. Research 7, 0365 (2024).","journal-title":"Research"},{"key":"2920_CR148","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1016\/j.cell.2025.03.048","volume":"188","author":"A Ziogas","year":"2025","unstructured":"Ziogas, A. et al. Long-term histone lactylation connects metabolic and epigenetic rewiring in innate immune memory. Cell 188, 2992\u20133012.e2916 (2025).","journal-title":"Cell"},{"key":"2920_CR149","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58563-2","volume":"16","author":"H Cai","year":"2025","unstructured":"Cai, H. et al. Lactate activates trained immunity by fueling the tricarboxylic acid cycle and regulating histone lactylation. Nat. Commun. 16, 3230 (2025).","journal-title":"Nat. Commun."},{"key":"2920_CR150","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07792-w","volume":"16","author":"Q Peng","year":"2025","unstructured":"Peng, Q. et al. KDM4B enhances immune surveillance via demethylating cGAS. Cell Death Dis. 16, 478 (2025).","journal-title":"Cell Death Dis."},{"key":"2920_CR151","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1016\/j.molcel.2022.05.027","volume":"82","author":"AB Herman","year":"2022","unstructured":"Herman, A. B., Tsitsipatis, D. & Gorospe, M. Integrated lncRNA function upon genomic and epigenomic regulation. Mol. Cell 82, 2252\u20132266 (2022).","journal-title":"Mol. Cell"},{"key":"2920_CR152","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41576-025-00836-z","volume":"26","author":"K Choquet","year":"2025","unstructured":"Choquet, K., Patop, I. L. & Churchman, L. S. The regulation and function of post-transcriptional RNA splicing. Nat. Rev. Genet. 26, 378\u2013394 (2025).","journal-title":"Nat. Rev. Genet."},{"key":"2920_CR153","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41580-022-00545-z","volume":"24","author":"LE Marasco","year":"2023","unstructured":"Marasco, L. E. & Kornblihtt, A. R. The physiology of alternative splicing. Nat. Rev. Mol. Cell Biol. 24, 242\u2013254 (2023).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2920_CR154","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-021-00811-1","volume":"20","author":"K Pustelny","year":"2022","unstructured":"Pustelny, K. et al. Mechanism of MyD88S-mediated signal termination. Cell Commun. Signal. 20, 10 (2022).","journal-title":"Cell Commun. Signal."},{"key":"2920_CR155","doi-asserted-by":"publisher","first-page":"168497","DOI":"10.1016\/j.jmb.2024.168497","volume":"436","author":"FFY Lee","year":"2024","unstructured":"Lee, F. F. Y., Harris, C. & Alper, S. RNA binding proteins that mediate LPS-induced alternative splicing of the MyD88 innate immune regulator. J. Mol. Biol. 436, 168497 (2024).","journal-title":"J. Mol. Biol."},{"key":"2920_CR156","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.cell.2014.01.021","volume":"156","author":"SW Brubaker","year":"2014","unstructured":"Brubaker, S. W. et al. A bicistronic MAVS transcript highlights a class of truncated variants in antiviral immunity. Cell 156, 800\u2013811 (2014).","journal-title":"Cell"},{"key":"2920_CR157","doi-asserted-by":"publisher","DOI":"10.1172\/JCI144339","volume":"132","author":"X Li","year":"2022","unstructured":"Li, X. et al. An alternatively spliced STING isoform localizes in the cytoplasmic membrane and directly senses extracellular cGAMP. J. Clin. Investig. 132, e144339 (2022).","journal-title":"J. Clin. Investig."},{"key":"2920_CR158","doi-asserted-by":"publisher","first-page":"105356","DOI":"10.1016\/j.dci.2025.105356","volume":"166","author":"X Zhu","year":"2025","unstructured":"Zhu, X. et al. Identification and functional regulation of two alternative splicing isoforms of the Uhrf2 gene in Miichthysmiiuy. Dev. Comp. Immunol. 166, 105356 (2025).","journal-title":"Dev. Comp. Immunol."},{"key":"2920_CR159","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/s41588-022-01113-z","volume":"54","author":"AR Banday","year":"2022","unstructured":"Banday, A. R. et al. Genetic regulation of OAS1 nonsense-mediated decay underlies association with COVID-19 hospitalization in patients of European and African ancestries. Nat. Genet. 54, 1103\u20131116 (2022).","journal-title":"Nat. Genet."},{"key":"2920_CR160","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1002\/1873-3468.70132","volume":"599","author":"MS Negi","year":"2025","unstructured":"Negi, M. S., Soskic, B. & Legnini, I. Regulation of mRNA metabolism in immune cells. FEBS Lett. 599, 2571\u20132581 (2025).","journal-title":"FEBS Lett."},{"key":"2920_CR161","doi-asserted-by":"publisher","first-page":"6769","DOI":"10.1093\/nar\/gkac513","volume":"50","author":"B Los","year":"2022","unstructured":"Los, B. et al. Body temperature variation controls pre-mRNA processing and transcription of antiviral genes and SARS-CoV-2 replication. Nucleic Acids Res. 50, 6769\u20136785 (2022).","journal-title":"Nucleic Acids Res."},{"key":"2920_CR162","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.tibs.2025.04.004","volume":"50","author":"A Panthi","year":"2025","unstructured":"Panthi, A. & Lynch, K. W. RNA processing in innate immunity: regulation by RNA-binding proteins. Trends Biochem. Sci. 50, 610\u2013621 (2025).","journal-title":"Trends Biochem. Sci."},{"key":"2920_CR163","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-biochem-052621-091808","volume":"92","author":"Q Wu","year":"2023","unstructured":"Wu, Q. & Bazzini, A. A. Translation and mRNA stability control. Annu. Rev. Biochem. 92, 227\u2013245 (2023).","journal-title":"Annu. Rev. Biochem."},{"key":"2920_CR164","doi-asserted-by":"publisher","first-page":"681","DOI":"10.4161\/rna.8.4.16283","volume":"8","author":"AS Halees","year":"2011","unstructured":"Halees, A. S. et al. Global assessment of GU-rich regulatory content and function in the human transcriptome. RNA Biol. 8, 681\u2013691 (2011).","journal-title":"RNA Biol."},{"key":"2920_CR165","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.cytogfr.2016.11.004","volume":"33","author":"I Vlasova-St Louis","year":"2017","unstructured":"Vlasova-St Louis, I. & Bohjanen, P. R. Post-transcriptional regulation of cytokine and growth factor signaling in cancer. Cytokine Growth Factor Rev. 33, 83\u201393 (2017).","journal-title":"Cytokine Growth Factor Rev."},{"key":"2920_CR166","first-page":"7418","volume":"44","author":"C Tiedje","year":"2016","unstructured":"Tiedje, C. et al. The RNA-binding protein TTP is a global post-transcriptional regulator of feedback control in inflammation. Nucleic Acids Res. 44, 7418\u20137440 (2016).","journal-title":"Nucleic Acids Res."},{"key":"2920_CR167","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1038\/s41586-025-09152-2","volume":"643","author":"KC Witt","year":"2025","unstructured":"Witt, K. C. et al. SP140-RESIST pathway regulates interferon mRNA stability and antiviral immunity. Nature 643, 1372\u20131380 (2025).","journal-title":"Nature"},{"key":"2920_CR168","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1016\/j.cellsig.2008.05.007","volume":"20","author":"A Doller","year":"2008","unstructured":"Doller, A., Pfeilschifter, J. & Eberhardt, W. Signalling pathways regulating nucleo-cytoplasmic shuttling of the mRNA-binding protein HuR. Cell Signal 20, 2165\u20132173 (2008).","journal-title":"Cell Signal"},{"key":"2920_CR169","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/PL00000854","volume":"58","author":"CM Brennan","year":"2001","unstructured":"Brennan, C. M. & Steitz, J. A. HuR and mRNA stability. Cell. Mol. Life Sci. 58, 266\u2013277 (2001).","journal-title":"Cell. Mol. Life Sci."},{"key":"2920_CR170","doi-asserted-by":"publisher","first-page":"6461","DOI":"10.1128\/MCB.21.9.6461-6469.2001","volume":"21","author":"KR Mahtani","year":"2001","unstructured":"Mahtani, K. R. et al. Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability. Mol. Cell. Biol. 21, 6461\u20136469 (2001).","journal-title":"Mol. Cell. Biol."},{"key":"2920_CR171","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/ni.2137","volume":"12","author":"H Iwasaki","year":"2011","unstructured":"Iwasaki, H. et al. The IkappaB kinase complex regulates the stability of cytokine-encoding mRNA induced by TLR-IL-1R by controlling degradation of regnase-1. Nat. Immunol. 12, 1167\u20131175 (2011).","journal-title":"Nat. Immunol."},{"key":"2920_CR172","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1101\/gr.124107.111","volume":"22","author":"JH Bahn","year":"2012","unstructured":"Bahn, J. H. et al. Accurate identification of A-to-I RNA editing in human by transcriptome sequencing. Genome Res. 22, 142\u2013150 (2012).","journal-title":"Genome Res."},{"key":"2920_CR173","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1016\/j.cell.2018.10.030","volume":"175","author":"D Arango","year":"2018","unstructured":"Arango, D. et al. Acetylation of cytidine in mRNA promotes translation efficiency. Cell 175, 1872\u20131886.e1824 (2018).","journal-title":"Cell"},{"key":"2920_CR174","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature12730","volume":"505","author":"X Wang","year":"2014","unstructured":"Wang, X. et al. N6-methyladenosine-dependent regulation of messenger RNA stability. Nature 505, 117\u2013120 (2014).","journal-title":"Nature"},{"key":"2920_CR175","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/s41556-019-0361-y","volume":"21","author":"X Chen","year":"2019","unstructured":"Chen, X. et al. 5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs. Nat. Cell Biol. 21, 978\u2013990 (2019).","journal-title":"Nat. Cell Biol."},{"key":"2920_CR176","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.molcel.2019.06.033","volume":"75","author":"Y Yang","year":"2019","unstructured":"Yang, Y. et al. RNA 5-methylcytosine facilitates the maternal-to-zygotic transition by preventing maternal mRNA decay. Mol. Cell 75, 1188\u20131202.e1111 (2019).","journal-title":"Mol. Cell"},{"key":"2920_CR177","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.cell.2014.08.028","volume":"159","author":"S Schwartz","year":"2014","unstructured":"Schwartz, S. et al. Transcriptome-wide mapping reveals widespread dynamic-regulated pseudouridylation of ncRNA and mRNA. Cell 159, 148\u2013162 (2014).","journal-title":"Cell"},{"key":"2920_CR178","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41576-022-00534-0","volume":"24","author":"K Boulias","year":"2023","unstructured":"Boulias, K. & Greer, E. L. Biological roles of adenine methylation in RNA. Nat. Rev. Genet. 24, 143\u2013160 (2023).","journal-title":"Nat. Rev. Genet."},{"key":"2920_CR179","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/0092-8674(75)90159-2","volume":"4","author":"RP Perry","year":"1975","unstructured":"Perry, R. P., Kelley, D. E., Friderici, K. & Rottman, F. The methylated constituents of L cell messenger RNA: evidence for an unusual cluster at the 5\u2019 terminus. Cell 4, 387\u2013394 (1975).","journal-title":"Cell"},{"key":"2920_CR180","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41590-018-0275-z","volume":"20","author":"R Winkler","year":"2019","unstructured":"Winkler, R. et al. m(6)A modification controls the innate immune response to infection by targeting type I interferons. Nat. Immunol. 20, 173\u2013182 (2019).","journal-title":"Nat. Immunol."},{"key":"2920_CR181","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.03349-22","volume":"14","author":"J Feng","year":"2023","unstructured":"Feng, J. et al. N(6)-methyladenosine and reader protein YTHDF2 enhance the innate immune response by mediating DUSP1 mRNA degradation and activating mitogen-activated protein kinases during bacterial and viral infections. mBio 14, e0334922 (2023).","journal-title":"mBio"},{"key":"2920_CR182","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4619","volume":"5","author":"X Zhou","year":"2014","unstructured":"Zhou, X. et al. MicroRNA-302b augments host defense to bacteria by regulating inflammatory responses via feedback to TLR\/IRAK4 circuits. Nat. Commun. 5, 3619 (2014).","journal-title":"Nat. Commun."},{"key":"2920_CR183","doi-asserted-by":"publisher","first-page":"16132","DOI":"10.1038\/nmicrobiol.2016.132","volume":"1","author":"X Li","year":"2016","unstructured":"Li, X. et al. Pseudomonas aeruginosa infection augments inflammation through miR-301b repression of c-Myb-mediated immune activation and infiltration. Nat. Microbiol. 1, 16132 (2016).","journal-title":"Nat. Microbiol."},{"key":"2920_CR184","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1038\/emboj.2011.94","volume":"30","author":"LN Schulte","year":"2011","unstructured":"Schulte, L. N. et al. Analysis of the host microRNA response to Salmonella uncovers the control of major cytokines by the let-7 family. EMBO J 30, 1977\u20131989 (2011).","journal-title":"EMBO J"},{"key":"2920_CR185","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1016\/j.febslet.2011.05.029","volume":"585","author":"Y Liu","year":"2011","unstructured":"Liu, Y. et al. MicroRNA-98 negatively regulates IL-10 production and endotoxin tolerance in macrophages after LPS stimulation. FEBS Lett. 585, 1963\u20131968 (2011).","journal-title":"FEBS Lett."},{"key":"2920_CR186","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nri2922","volume":"11","author":"D Mathis","year":"2011","unstructured":"Mathis, D. & Shoelson, S. E. Immunometabolism: an emerging frontier. Nat. Rev. Immunol. 11, 81 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"2920_CR187","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1146\/annurev-immunol-032713-120236","volume":"32","author":"K Ganeshan","year":"2014","unstructured":"Ganeshan, K. & Chawla, A. Metabolic regulation of immune responses. Annu. Rev. Immunol. 32, 609\u2013634 (2014).","journal-title":"Annu. Rev. Immunol."},{"key":"2920_CR188","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.immuni.2013.04.005","volume":"38","author":"EL Pearce","year":"2013","unstructured":"Pearce, E. L. & Pearce, E. J. Metabolic pathways in immune cell activation and quiescence. Immunity 38, 633\u2013643 (2013).","journal-title":"Immunity"},{"key":"2920_CR189","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/cr.2015.68","volume":"25","author":"B Kelly","year":"2015","unstructured":"Kelly, B. & O\u2019Neill, L. A. Metabolic reprogramming in macrophages and dendritic cells in innate immunity. Cell Res. 25, 771\u2013784 (2015).","journal-title":"Cell Res."},{"key":"2920_CR190","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.cmet.2017.06.001","volume":"26","author":"R Stienstra","year":"2017","unstructured":"Stienstra, R. et al. Specific and complex reprogramming of cellular metabolism in myeloid cells during innate immune responses. Cell Metab. 26, 142\u2013156 (2017).","journal-title":"Cell Metab."},{"key":"2920_CR191","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.cmet.2017.06.018","volume":"26","author":"T Pr\u00f3chnicki","year":"2017","unstructured":"Pr\u00f3chnicki, T. & Latz, E. Inflammasomes on the crossroads of innate immune recognition and metabolic control. Cell Metab. 26, 71\u201393 (2017).","journal-title":"Cell Metab."},{"key":"2920_CR192","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12950-025-00457-7","volume":"22","author":"R Mann","year":"2025","unstructured":"Mann, R., Stavrou, V. & Dimeloe, S. NAD + metabolism and function in innate and adaptive immune cells. J. Inflamm. 22, 30 (2025).","journal-title":"J. Inflamm."},{"key":"2920_CR193","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nature11986","volume":"496","author":"GM Tannahill","year":"2013","unstructured":"Tannahill, G. M. et al. Succinate is an inflammatory signal that induces IL-1\u03b2 through HIF-1\u03b1. Nature 496, 238\u2013242 (2013).","journal-title":"Nature"},{"key":"2920_CR194","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cmet.2014.12.005","volume":"21","author":"EM Palsson-McDermott","year":"2015","unstructured":"Palsson-McDermott, E. M. et al. Pyruvate kinase M2 regulates Hif-1alpha activity and IL-1beta induction and is a critical determinant of the warburg effect in LPS-activated macrophages. Cell Metab. 21, 65\u201380 (2015).","journal-title":"Cell Metab."},{"key":"2920_CR195","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1161\/CIRCULATIONAHA.120.046464","volume":"144","author":"L Edgar","year":"2021","unstructured":"Edgar, L. et al. Hyperglycemia induces trained immunity in macrophages and their precursors and promotes atherosclerosis. Circulation 144, 961\u2013982 (2021).","journal-title":"Circulation"},{"key":"2920_CR196","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00281-024-01015-8","volume":"46","author":"AV Ferreira","year":"2024","unstructured":"Ferreira, A. V. et al. Metabolic regulation in the induction of trained immunity. Semin. Immunopathol. 46, 7 (2024).","journal-title":"Semin. Immunopathol."},{"key":"2920_CR197","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-020-00251-y","volume":"9","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. Metabolic reprogramming in macrophage responses. Biomark. Res. 9, 1 (2021).","journal-title":"Biomark. Res."},{"key":"2920_CR198","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.immuni.2019.11.009","volume":"51","author":"MA Lauterbach","year":"2019","unstructured":"Lauterbach, M. A. et al. Toll-like receptor signaling rewires macrophage metabolism and promotes histone acetylation via ATP-citrate lyase. Immunity 51, 997\u20131011.e1017 (2019).","journal-title":"Immunity"},{"key":"2920_CR199","doi-asserted-by":"publisher","first-page":"1250684","DOI":"10.1126\/science.1250684","volume":"345","author":"SC Cheng","year":"2014","unstructured":"Cheng, S. C. et al. mTOR- and HIF-1\u03b1-mediated aerobic glycolysis as metabolic basis for trained immunity. Science 345, 1250684 (2014).","journal-title":"Science"},{"key":"2920_CR200","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.tcb.2020.09.006","volume":"30","author":"J Yan","year":"2020","unstructured":"Yan, J. & Horng, T. Lipid metabolism in regulation of macrophage functions. Trends Cell Biol. 30, 979\u2013989 (2020).","journal-title":"Trends Cell Biol."},{"key":"2920_CR201","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.scib.2024.07.049","volume":"70","author":"Q Zhang","year":"2025","unstructured":"Zhang, Q. et al. Specialized pro-resolving lipid mediators: a key player in resolving inflammation in autoimmune diseases. Sci. Bull. 70, 778\u2013794 (2025).","journal-title":"Sci. Bull."},{"key":"2920_CR202","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.it.2017.03.001","volume":"38","author":"J Van den Bossche","year":"2017","unstructured":"Van den Bossche, J., O\u2019Neill, L. A. & Menon, D. Macrophage immunometabolism: where are we (going)? Trends Immunol. 38, 395\u2013406 (2017).","journal-title":"Trends Immunol."},{"key":"2920_CR203","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.mce.2012.02.004","volume":"366","author":"MD Fullerton","year":"2013","unstructured":"Fullerton, M. D., Steinberg, G. R. & Schertzer, J. D. Immunometabolism of AMPK in insulin resistance and atherosclerosis. Mol. Cell. Endocrinol. 366, 224\u2013234 (2013).","journal-title":"Mol. Cell. Endocrinol."},{"key":"2920_CR204","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/ni.3366","volume":"17","author":"M Nomura","year":"2016","unstructured":"Nomura, M. et al. Fatty acid oxidation in macrophage polarization. Nat. Immunol. 17, 216\u2013217 (2016).","journal-title":"Nat. Immunol."},{"key":"2920_CR205","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.cmet.2018.06.001","volume":"28","author":"AS Divakaruni","year":"2018","unstructured":"Divakaruni, A. S. et al. Etomoxir inhibits macrophage polarization by disrupting CoA homeostasis. Cell Metab. 28, 490\u2013503 e497 (2018).","journal-title":"Cell Metab."},{"key":"2920_CR206","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.immuni.2017.08.005","volume":"47","author":"T Riffelmacher","year":"2017","unstructured":"Riffelmacher, T. et al. Autophagy-dependent generation of free fatty acids is critical for normal neutrophil differentiation. Immunity 47, 466\u2013480.e465 (2017).","journal-title":"Immunity"},{"key":"2920_CR207","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/nature08938","volume":"464","author":"P Duewell","year":"2010","unstructured":"Duewell, P. et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464, 1357\u20131361 (2010).","journal-title":"Nature"},{"key":"2920_CR208","doi-asserted-by":"publisher","first-page":"3480","DOI":"10.1039\/C6FO00477F","volume":"7","author":"N Martinez-Micaelo","year":"2016","unstructured":"Martinez-Micaelo, N. et al. Dietary fatty acid composition is sensed by the NLRP3 inflammasome: omega-3 fatty acid (DHA) prevents NLRP3 activation in human macrophages. Food Funct. 7, 3480\u20133487 (2016).","journal-title":"Food Funct."},{"key":"2920_CR209","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1161\/01.ATV.20.3.773","volume":"20","author":"NL Jones","year":"2000","unstructured":"Jones, N. L., Reagan, J. W. & Willingham, M. C. The pathogenesis of foam cell formation: modified LDL stimulates uptake of co-incubated LDL via macropinocytosis. Arterioscler. Thromb. Vasc. Biol. 20, 773\u2013781 (2000).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2920_CR210","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.cmet.2016.10.008","volume":"24","author":"RJ Arts","year":"2016","unstructured":"Arts, R. J. et al. Glutaminolysis and fumarate accumulation integrate immunometabolic and epigenetic programs in trained immunity. Cell Metab. 24, 807\u2013819 (2016).","journal-title":"Cell Metab."},{"key":"2920_CR211","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.cell.2017.11.025","volume":"172","author":"S Bekkering","year":"2018","unstructured":"Bekkering, S. et al. Metabolic induction of trained immunity through the mevalonate pathway. Cell 172, 135\u2013146.e139 (2018).","journal-title":"Cell"},{"key":"2920_CR212","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.cmet.2020.06.010","volume":"32","author":"B Kelly","year":"2020","unstructured":"Kelly, B. & Pearce, E. L. Amino assets: how amino acids support immunity. Cell Metab. 32, 154\u2013175 (2020).","journal-title":"Cell Metab."},{"key":"2920_CR213","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1021\/acsnano.4c12036","volume":"19","author":"J Wu","year":"2025","unstructured":"Wu, J. et al. Biomimetic \u201cTrojan Horse\u201d fibers modulate innate immunity cascades for nerve regeneration. ACS Nano 19, 781\u2013802 (2025).","journal-title":"ACS Nano"},{"key":"2920_CR214","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14433-7","volume":"11","author":"EM Palmieri","year":"2020","unstructured":"Palmieri, E. M. et al. Nitric oxide orchestrates metabolic rewiring in M1 macrophages by targeting aconitase 2 and pyruvate dehydrogenase. Nat. Commun. 11, 698 (2020).","journal-title":"Nat. Commun."},{"key":"2920_CR215","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06147-7","volume":"14","author":"E Shosha","year":"2023","unstructured":"Shosha, E. et al. The arginase 1\/ornithine decarboxylase pathway suppresses HDAC3 to ameliorate the myeloid cell inflammatory response: implications for retinal ischemic injury. Cell Death Dis. 14, 621 (2023).","journal-title":"Cell Death Dis."},{"key":"2920_CR216","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00281-025-01038-9","volume":"47","author":"E Karadima","year":"2025","unstructured":"Karadima, E., Chavakis, T. & Alexaki, V. I. Arginine metabolism in myeloid cells in health and disease. Semin. Immunopathol. 47, 11 (2025).","journal-title":"Semin. Immunopathol."},{"key":"2920_CR217","doi-asserted-by":"publisher","first-page":"e00458","DOI":"10.1128\/IAI.00458-17","volume":"86","author":"T Kerrinnes","year":"2018","unstructured":"Kerrinnes, T. et al. Utilization of host polyamines in alternatively activated macrophages promotes chronic infection by Brucella abortus. Infect. Immun. 86, e00458\u201317 (2018).","journal-title":"Infect. Immun."},{"key":"2920_CR218","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/ni.3421","volume":"17","author":"LA Monticelli","year":"2016","unstructured":"Monticelli, L. A. et al. Arginase 1 is an innate lymphoid-cell-intrinsic metabolic checkpoint controlling type 2 inflammation. Nat. Immunol. 17, 656\u2013665 (2016).","journal-title":"Nat. Immunol."},{"key":"2920_CR219","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1038\/s41551-023-01025-1","volume":"7","author":"E Bracho-Sanchez","year":"2023","unstructured":"Bracho-Sanchez, E. et al. Suppression of local inflammation via galectin-anchored indoleamine 2,3-dioxygenase. Nat. Biomed. Eng. 7, 1156\u20131169 (2023).","journal-title":"Nat. Biomed. Eng."},{"key":"2920_CR220","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17750-z","volume":"11","author":"LF Campesato","year":"2020","unstructured":"Campesato, L. F. et al. Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine. Nat. Commun. 11, 4011 (2020).","journal-title":"Nat. Commun."},{"key":"2920_CR221","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature10491","volume":"478","author":"CA Opitz","year":"2011","unstructured":"Opitz, C. A. et al. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature 478, 197\u2013203 (2011).","journal-title":"Nature"},{"key":"2920_CR222","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/nri2233","volume":"8","author":"AL Mellor","year":"2008","unstructured":"Mellor, A. L. & Munn, D. H. Creating immune privilege: active local suppression that benefits friends, but protects foes. Nat. Rev. Immunol. 8, 74\u201380 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"2920_CR223","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1093\/intimm\/dxaa019","volume":"32","author":"M Miyajima","year":"2020","unstructured":"Miyajima, M. Amino acids: key sources for immunometabolites and immunotransmitters. Int. Immunol. 32, 435\u2013446 (2020).","journal-title":"Int. Immunol."},{"key":"2920_CR224","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.immuni.2019.01.007","volume":"50","author":"X Li","year":"2019","unstructured":"Li, X. et al. O-GlcNAc transferase suppresses inflammation and necroptosis by targeting receptor-interacting serine\/threonine-protein kinase 3. Immunity 50, 576\u2013590.e576 (2019).","journal-title":"Immunity"},{"key":"2920_CR225","doi-asserted-by":"publisher","first-page":"101930","DOI":"10.1016\/j.redox.2021.101930","volume":"41","author":"T Zhang","year":"2021","unstructured":"Zhang, T. et al. ATP exposure stimulates glutathione efflux as a necessary switch for NLRP3 inflammasome activation. Redox Biol. 41, 101930 (2021).","journal-title":"Redox Biol."},{"key":"2920_CR226","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/j.cmet.2025.05.012","volume":"37","author":"M Shan","year":"2025","unstructured":"Shan, M. et al. Itaconate promotes inflammatory responses in tissue-resident alveolar macrophages and exacerbates acute lung injury. Cell Metab. 37, 1750\u20131765.e1757 (2025).","journal-title":"Cell Metab."},{"key":"2920_CR227","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/j.cell.2026.01.023","volume":"189","author":"Y Zuo","year":"2026","unstructured":"Zuo, Y. et al. Pyruvate is a natural suppressor of interferon signaling by inducing STAT1 protein pyruvylation. Cell 189, 1975\u20131989 (2026).","journal-title":"Cell"},{"key":"2920_CR228","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41392-024-02043-4","volume":"10","author":"X Zhou","year":"2025","unstructured":"Zhou, X. et al. Mucosal immune response in biology, disease prevention and treatment. Signal Transduct. Target Ther. 10, 7 (2025).","journal-title":"Signal Transduct. Target Ther."},{"key":"2920_CR229","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.0022-202X.2005.23668.x","volume":"125","author":"PM Elias","year":"2005","unstructured":"Elias, P. M. Stratum corneum defensive functions: an integrated view. J. Investig. Dermatol. 125, 183\u2013200 (2005).","journal-title":"J. Investig. Dermatol."},{"key":"2920_CR230","doi-asserted-by":"publisher","first-page":"a028241","DOI":"10.1101\/cshperspect.a028241","volume":"9","author":"XM Bustamante-Marin","year":"2017","unstructured":"Bustamante-Marin, X. M. & Ostrowski, L. E. Cilia and mucociliary clearance. Cold Spring Harb. Perspect. Biol. 9, a028241 (2017).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"2920_CR231","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/s41392-023-01553-x","volume":"8","author":"J Fu","year":"2023","unstructured":"Fu, J. et al. Mechanisms and regulation of defensins in host defense. Signal Transduct. Target Ther. 8, 300 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"2920_CR232","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s12038-010-0015-5","volume":"35","author":"L Callewaert","year":"2010","unstructured":"Callewaert, L. & Michiels, C. W. Lysozymes in the animal kingdom. J. Biosci. 35, 127\u2013160 (2010).","journal-title":"J. Biosci."},{"key":"2920_CR233","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1007\/s00018-005-5370-2","volume":"62","author":"D Legrand","year":"2005","unstructured":"Legrand, D., Elass, E., Carpentier, M. & Mazurier, J. Lactoferrin: a modulator of immune and inflammatory responses. Cell. Mol. Life Sci. 62, 2549\u20132559 (2005).","journal-title":"Cell. Mol. Life Sci."},{"key":"2920_CR234","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nri1528","volume":"5","author":"JR Wright","year":"2005","unstructured":"Wright, J. R. Immunoregulatory functions of surfactant proteins. Nat. Rev. Immunol. 5, 58\u201368 (2005).","journal-title":"Nat. Rev. Immunol."},{"key":"2920_CR235","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1742-7843.2005.pto960202.x","volume":"96","author":"TC Martinsen","year":"2005","unstructured":"Martinsen, T. C., Bergh, K. & Waldum, H. L. Gastric juice: a barrier against infectious diseases. Basic Clin. Pharmacol. Toxicol. 96, 94\u2013102 (2005).","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"2920_CR236","doi-asserted-by":"publisher","first-page":"245","DOI":"10.33549\/physiolres.930448","volume":"53","author":"I Str\u00edz","year":"2004","unstructured":"Str\u00edz, I. & Trebichavsk\u00fd, I. Calprotectin - a pleiotropic molecule in acute and chronic inflammation. Physiol. Res. 53, 245\u2013253 (2004).","journal-title":"Physiol. Res."},{"key":"2920_CR237","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/nchembio.1891","volume":"11","author":"TG Nakashige","year":"2015","unstructured":"Nakashige, T. G., Zhang, B., Krebs, C. & Nolan, E. M. Human calprotectin is an iron-sequestering host-defense protein. Nat. Chem. Biol. 11, 765\u2013771 (2015).","journal-title":"Nat. Chem. Biol."},{"key":"2920_CR238","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/nm1638","volume":"13","author":"T Vogl","year":"2007","unstructured":"Vogl, T. et al. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat. Med. 13, 1042\u20131049 (2007).","journal-title":"Nat. Med."},{"key":"2920_CR239","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nri3399","volume":"13","author":"E Kolaczkowska","year":"2013","unstructured":"Kolaczkowska, E. & Kubes, P. Neutrophil recruitment and function in health and inflammation. Nat. Rev. Immunol. 13, 159\u2013175 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"2920_CR240","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/ni.2921","volume":"15","author":"WM Nauseef","year":"2014","unstructured":"Nauseef, W. M. & Borregaard, N. Neutrophils at work. Nat. Immunol. 15, 602\u2013611 (2014).","journal-title":"Nat. Immunol."},{"key":"2920_CR241","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.micinf.2003.09.008","volume":"5","author":"M Faurschou","year":"2003","unstructured":"Faurschou, M. & Borregaard, N. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect. 5, 1317\u20131327 (2003).","journal-title":"Microbes Infect."},{"key":"2920_CR242","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1126\/science.1092385","volume":"303","author":"V Brinkmann","year":"2004","unstructured":"Brinkmann, V. et al. Neutrophil extracellular traps kill bacteria. Science 303, 1532\u20131535 (2004).","journal-title":"Science"},{"key":"2920_CR243","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/ni.1863","volume":"11","author":"T Kawai","year":"2010","unstructured":"Kawai, T. & Akira, S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11, 373\u2013384 (2010).","journal-title":"Nat. Immunol."},{"key":"2920_CR244","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nri3073","volume":"11","author":"PJ Murray","year":"2011","unstructured":"Murray, P. J. & Wynn, T. A. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 11, 723\u2013737 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"2920_CR245","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1146\/annurev-pathol-011811-132445","volume":"7","author":"RS Flannagan","year":"2012","unstructured":"Flannagan, R. S., Jaumouill\u00e9, V. & Grinstein, S. The cell biology of phagocytosis. Annu. Rev. Pathol. 7, 61\u201398 (2012).","journal-title":"Annu. Rev. Pathol."},{"key":"2920_CR246","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.immuni.2016.02.024","volume":"44","author":"F Ginhoux","year":"2016","unstructured":"Ginhoux, F. & Guilliams, M. Tissue-resident macrophage ontogeny and homeostasis. Immunity 44, 439\u2013449 (2016).","journal-title":"Immunity"},{"key":"2920_CR247","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41577-023-00848-y","volume":"23","author":"E Mass","year":"2023","unstructured":"Mass, E., Nimmerjahn, F., Kierdorf, K. & Schlitzer, A. Tissue-specific macrophages: how they develop and choreograph tissue biology. Nat. Rev. Immunol. 23, 563\u2013579 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"2920_CR248","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.immuni.2020.05.014","volume":"52","author":"C Bl\u00e9riot","year":"2020","unstructured":"Bl\u00e9riot, C., Chakarov, S. & Ginhoux, F. Determinants of resident tissue macrophage identity and function. Immunity 52, 957\u2013970 (2020).","journal-title":"Immunity"},{"key":"2920_CR249","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.immuni.2019.08.017","volume":"51","author":"J Bonnardel","year":"2019","unstructured":"Bonnardel, J. et al. Stellate cells, hepatocytes, and endothelial cells imprint the kupffer cell identity on monocytes colonizing the liver macrophage niche. Immunity 51, 638\u2013654.e639 (2019).","journal-title":"Immunity"},{"key":"2920_CR250","doi-asserted-by":"publisher","first-page":"aaa6566","DOI":"10.1126\/science.aaa6566","volume":"348","author":"G Eberl","year":"2015","unstructured":"Eberl, G., Colonna, M., Di Santo, J. P. & McKenzie, A. N. J. Innate lymphoid cells: a new paradigm in immunology. Science 348, aaa6566 (2015).","journal-title":"Science"},{"key":"2920_CR251","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41577-019-0194-8","volume":"19","author":"GF Sonnenberg","year":"2019","unstructured":"Sonnenberg, G. F. & Hepworth, M. R. Functional interactions between innate lymphoid cells and adaptive immunity. Nat. Rev. Immunol. 19, 599\u2013613 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"2920_CR252","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41590-025-02414-1","volume":"27","author":"A Das","year":"2026","unstructured":"Das, A., Ding, Y., Harly, C. & Bhandoola, A. The development of innate lymphoid cells. Nat. Immunol. 27, 401\u2013412 (2026).","journal-title":"Nat. Immunol."},{"key":"2920_CR253","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","volume":"174","author":"E Vivier","year":"2018","unstructured":"Vivier, E. et al. Innate lymphoid cells: 10 years on. Cell 174, 1054\u20131066 (2018).","journal-title":"Cell"},{"key":"2920_CR254","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1126\/science.1198687","volume":"331","author":"E Vivier","year":"2011","unstructured":"Vivier, E. et al. Innate or adaptive immunity? The example of natural killer cells. Science 331, 44\u201349 (2011).","journal-title":"Science"},{"key":"2920_CR255","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/ni1582","volume":"9","author":"E Vivier","year":"2008","unstructured":"Vivier, E. et al. Functions of natural killer cells. Nat. Immunol. 9, 503\u2013510 (2008).","journal-title":"Nat. Immunol."},{"key":"2920_CR256","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.cell.2014.03.030","volume":"157","author":"CSN Klose","year":"2014","unstructured":"Klose, C. S. N. et al. Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell 157, 340\u2013356 (2014).","journal-title":"Cell"},{"key":"2920_CR257","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.chom.2015.06.011","volume":"18","author":"MC Abt","year":"2015","unstructured":"Abt, M. C. et al. Innate immune defenses mediated by two ILC subsets are critical for protection against acute Clostridium difficile infection. Cell Host Microbe 18, 27\u201337 (2015).","journal-title":"Cell Host Microbe"},{"key":"2920_CR258","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/nri.2017.86","volume":"17","author":"M Ebbo","year":"2017","unstructured":"Ebbo, M., Crinier, A., V\u00e9ly, F. & Vivier, E. Innate lymphoid cells: major players in inflammatory diseases. Nat. Rev. Immunol. 17, 665\u2013678 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"2920_CR259","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1016\/j.fmre.2023.10.021","volume":"5","author":"YT Hu","year":"2025","unstructured":"Hu, Y. T., Liu, X. Z., Zhang, Y. M. & Guo, X. The interaction network between group 3 innate lymphoid cells and other cells. Fundam. Res. 5, 2937\u20132947 (2025).","journal-title":"Fundam. Res."},{"key":"2920_CR260","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nri3349","volume":"13","author":"JA Walker","year":"2013","unstructured":"Walker, J. A., Barlow, J. L. & McKenzie, A. N. J. Innate lymphoid cells \u2014 how did we miss them? Nat. Rev. Immunol. 13, 75\u201387 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"2920_CR261","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S1074-7613(00)80371-4","volume":"7","author":"RE Mebius","year":"1997","unstructured":"Mebius, R. E., Rennert, P. & Weissman, I. L. Developing lymph nodes collect CD4+CD3- LTbeta+ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity 7, 493\u2013504 (1997).","journal-title":"Immunity"},{"key":"2920_CR262","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1146\/annurev-immunol-061020-053707","volume":"39","author":"M Cabeza-Cabrerizo","year":"2021","unstructured":"Cabeza-Cabrerizo, M. et al. Dendritic cells revisited. Annu. Rev. Immunol. 39, 131\u2013166 (2021).","journal-title":"Annu. Rev. Immunol."},{"key":"2920_CR263","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1146\/annurev-immunol-020711-074950","volume":"31","author":"M Merad","year":"2013","unstructured":"Merad, M. et al. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu. Rev. Immunol. 31, 563\u2013604 (2013).","journal-title":"Annu. Rev. Immunol."},{"key":"2920_CR264","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1038\/s41423-021-00726-4","volume":"18","author":"J Liu","year":"2021","unstructured":"Liu, J., Zhang, X., Cheng, Y. & Cao, X. Dendritic cell migration in inflammation and immunity. Cell. Mol. Immunol. 18, 2461\u20132471 (2021).","journal-title":"Cell. Mol. Immunol."},{"key":"2920_CR265","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nri3608","volume":"14","author":"LW Peterson","year":"2014","unstructured":"Peterson, L. W. & Artis, D. Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat. Rev. Immunol. 14, 141\u2013153 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"2920_CR266","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.immuni.2019.03.025","volume":"50","author":"HM Lazear","year":"2019","unstructured":"Lazear, H. M., Schoggins, J. W. & Diamond, M. S. Shared and distinct functions of type I and type III interferons. Immunity 50, 907\u2013923 (2019).","journal-title":"Immunity"},{"key":"2920_CR267","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.immuni.2015.07.001","volume":"43","author":"HM Lazear","year":"2015","unstructured":"Lazear, H. M., Nice, T. J. & Diamond, M. S. Interferon-\u03bb: immune functions at barrier surfaces and beyond. Immunity 43, 15\u201328 (2015).","journal-title":"Immunity"},{"key":"2920_CR268","doi-asserted-by":"publisher","first-page":"102400","DOI":"10.1016\/j.coi.2023.102400","volume":"86","author":"ML Stanifer","year":"2024","unstructured":"Stanifer, M. L. & Boulant, S. Differential signaling by type-I and type-III interferons in mucosa. Curr. Opin. Immunol. 86, 102400 (2024).","journal-title":"Curr. Opin. Immunol."},{"key":"2920_CR269","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.1016\/j.cell.2021.06.024","volume":"184","author":"MV Plikus","year":"2021","unstructured":"Plikus, M. V. et al. Fibroblasts: origins, definitions, and functions in health and disease. Cell 184, 3852\u20133872 (2021).","journal-title":"Cell"},{"key":"2920_CR270","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41577-021-00540-z","volume":"21","author":"S Davidson","year":"2021","unstructured":"Davidson, S. et al. Fibroblasts as immune regulators in infection, inflammation and cancer. Nat. Rev. Immunol. 21, 704\u2013717 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"2920_CR271","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41577-024-00996-9","volume":"24","author":"KS Forsyth","year":"2024","unstructured":"Forsyth, K. S. et al. The conneXion between sex and immune responses. Nat. Rev. Immunol. 24, 487\u2013502 (2024).","journal-title":"Nat. Rev. Immunol."},{"key":"2920_CR272","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/nature24265","volume":"550","author":"T Tukiainen","year":"2017","unstructured":"Tukiainen, T. et al. Landscape of X chromosome inactivation across human tissues. Nature 550, 244\u2013248 (2017).","journal-title":"Nature"},{"key":"2920_CR273","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nature03479","volume":"434","author":"L Carrel","year":"2005","unstructured":"Carrel, L. & Willard, H. F. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 434, 400\u2013404 (2005).","journal-title":"Nature"},{"key":"2920_CR274","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00439-011-1011-z","volume":"130","author":"JB Berletch","year":"2011","unstructured":"Berletch, J. B. et al. Genes that escape from X inactivation. Hum. Genet. 130, 237\u2013245 (2011).","journal-title":"Hum. Genet."},{"key":"2920_CR275","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aap8855","volume":"3","author":"M Souyris","year":"2018","unstructured":"Souyris, M. et al. TLR7 escapes X chromosome inactivation in immune cells. Sci. Immunol. 3, eaap8855 (2018).","journal-title":"Sci. Immunol."},{"key":"2920_CR276","doi-asserted-by":"publisher","first-page":"5327","DOI":"10.4049\/jimmunol.1501684","volume":"195","author":"M Griesbeck","year":"2015","unstructured":"Griesbeck, M. et al. Sex differences in plasmacytoid dendritic cell levels of IRF5 drive higher IFN-\u03b1 production in women. J. Immunol. 195, 5327\u20135336 (2015).","journal-title":"J. Immunol."},{"key":"2920_CR277","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1016\/j.immuni.2023.10.008","volume":"56","author":"JP Hoffmann","year":"2023","unstructured":"Hoffmann, J. P., Liu, J. A., Seddu, K. & Klein, S. L. Sex hormone signaling and regulation of immune function. Immunity 56, 2472\u20132491 (2023).","journal-title":"Immunity"},{"key":"2920_CR278","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ccell.2025.02.013","volume":"43","author":"F Conforti","year":"2025","unstructured":"Conforti, F. et al. Sex hormones, the anticancer immune response, and therapeutic opportunities. Cancer Cell 43, 343\u2013360 (2025).","journal-title":"Cancer Cell"},{"key":"2920_CR279","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1210\/er.2007-0001","volume":"28","author":"RH Straub","year":"2007","unstructured":"Straub, R. H. The complex role of estrogens in inflammation. Endocr. Rev. 28, 521\u2013574 (2007).","journal-title":"Endocr. Rev."},{"key":"2920_CR280","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/intimm\/dxl145","volume":"19","author":"CL Butts","year":"2007","unstructured":"Butts, C. L. et al. Progesterone inhibits mature rat dendritic cells in a receptor-mediated fashion. Int. Immunol. 19, 287\u2013296 (2007).","journal-title":"Int. Immunol."},{"key":"2920_CR281","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s41584-020-0503-4","volume":"16","author":"M Cutolo","year":"2020","unstructured":"Cutolo, M. & Straub, R. H. Sex steroids and autoimmune rheumatic diseases: state of the art. Nat. Rev. Rheumatol. 16, 628\u2013644 (2020).","journal-title":"Nat. Rev. Rheumatol."},{"key":"2920_CR282","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1182\/blood-2003-02-0649","volume":"102","author":"EJ Molloy","year":"2003","unstructured":"Molloy, E. J. et al. Sex-specific alterations in neutrophil apoptosis: the role of estradiol and progesterone. Blood 102, 2653\u20132659 (2003).","journal-title":"Blood"},{"key":"2920_CR283","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1002\/cyto.a.20942","volume":"77","author":"I Heimbeck","year":"2010","unstructured":"Heimbeck, I. et al. Standardized single-platform assay for human monocyte subpopulations: lower CD14+CD16++ monocytes in females. Cytometry A 77, 823\u2013830 (2010).","journal-title":"Cytometry A"},{"key":"2920_CR284","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1126\/science.adx4381","volume":"389","author":"S Sharma","year":"2025","unstructured":"Sharma, S., Gibbons, A. & Saphire, E. O. Sex differences in tissue-specific immunity and immunology. Science 389, 599\u2013603 (2025).","journal-title":"Science"},{"key":"2920_CR285","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nri2075","volume":"7","author":"O Levy","year":"2007","unstructured":"Levy, O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat. Rev. Immunol. 7, 379\u2013390 (2007).","journal-title":"Nat. Rev. Immunol."},{"key":"2920_CR286","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1046\/j.1365-2141.2000.01992.x","volume":"110","author":"R Carr","year":"2000","unstructured":"Carr, R. Neutrophil production and function in newborn infants. Br. J. Haematol. 110, 18\u201328 (2000).","journal-title":"Br. J. Haematol."},{"key":"2920_CR287","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0165-0378(02)00022-0","volume":"56","author":"CA Jones","year":"2002","unstructured":"Jones, C. A., Holloway, J. A. & Warner, J. O. Phenotype of fetal monocytes and B lymphocytes during the third trimester of pregnancy. J. Reprod. Immunol. 56, 45\u201360 (2002).","journal-title":"J. Reprod. Immunol."},{"key":"2920_CR288","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1203\/01.PDR.0000163397.53466.0F","volume":"58","author":"E F\u00f6rster-Waldl","year":"2005","unstructured":"F\u00f6rster-Waldl, E. et al. Monocyte toll-like receptor 4 expression and LPS-induced cytokine production increase during gestational aging. Pediatr. Res. 58, 121\u2013124 (2005).","journal-title":"Pediatr. Res."},{"key":"2920_CR289","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1189\/jlb.1011525","volume":"93","author":"SS Sch\u00fcller","year":"2013","unstructured":"Sch\u00fcller, S. S. et al. Preterm neonates display altered plasmacytoid dendritic cell function and morphology. J. Leukoc. Biol. 93, 781\u2013788 (2013).","journal-title":"J. Leukoc. Biol."},{"key":"2920_CR290","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1172\/JCI68989","volume":"123","author":"MA Ivarsson","year":"2013","unstructured":"Ivarsson, M. A. et al. Differentiation and functional regulation of human fetal NK cells. J. Clin. Investig. 123, 3889\u20133901 (2013).","journal-title":"J. Clin. Investig."},{"key":"2920_CR291","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.imbio.2011.07.027","volume":"217","author":"EP McGreal","year":"2012","unstructured":"McGreal, E. P., Hearne, K. & Spiller, O. B. Off to a slow start: under-development of the complement system in term newborns is more substantial following premature birth. Immunobiology 217, 176\u2013186 (2012).","journal-title":"Immunobiology"},{"key":"2920_CR292","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1016\/j.immuni.2025.10.009","volume":"58","author":"M Terekhova","year":"2025","unstructured":"Terekhova, M., Bohacova, P. & Artyomov, M. N. Human immune aging. Immunity 58, 2646\u20132669 (2025).","journal-title":"Immunity"},{"key":"2920_CR293","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/imr.13153","volume":"314","author":"K Van Avondt","year":"2023","unstructured":"Van Avondt, K. et al. Neutrophils in aging and aging-related pathologies. Immunol. Rev. 314, 357\u2013375 (2023).","journal-title":"Immunol. Rev."},{"key":"2920_CR294","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1016\/j.immuni.2021.04.025","volume":"54","author":"A Barkaway","year":"2021","unstructured":"Barkaway, A. et al. Age-related changes in the local milieu of inflamed tissues cause aberrant neutrophil trafficking and subsequent remote organ damage. Immunity 54, 1494\u20131510.e1497 (2021).","journal-title":"Immunity"},{"key":"2920_CR295","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1007\/s10875-010-9448-8","volume":"30","author":"J Nyugen","year":"2010","unstructured":"Nyugen, J., Agrawal, S., Gollapudi, S. & Gupta, S. Impaired functions of peripheral blood monocyte subpopulations in aged humans. J. Clin. Immunol. 30, 806\u2013813 (2010).","journal-title":"J. Clin. Immunol."},{"key":"2920_CR296","doi-asserted-by":"publisher","first-page":"16018","DOI":"10.1038\/npjamd.2016.18","volume":"2","author":"Y Oishi","year":"2016","unstructured":"Oishi, Y. & Manabe, I. Macrophages in age-related chronic inflammatory diseases. npj Aging Mech. Dis. 2, 16018 (2016).","journal-title":"npj Aging Mech. Dis."},{"key":"2920_CR297","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41420-023-01497-9","volume":"9","author":"H Hu","year":"2023","unstructured":"Hu, H. et al. Defective efferocytosis by aged macrophages promotes STING signaling-mediated inflammatory liver injury. Cell Death Discov. 9, 236 (2023).","journal-title":"Cell Death Discov."},{"key":"2920_CR298","doi-asserted-by":"crossref","unstructured":"Jang, I. H., Niedernhofer, L. J., Robbins, P. D. & Camell, C. D. The ageing immune system as a driver of systemic ageing. Nat. Rev. Immunol. (2026).","DOI":"10.1038\/s41577-026-01269-3"},{"key":"2920_CR299","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s10875-010-9374-9","volume":"30","author":"DH Canaday","year":"2010","unstructured":"Canaday, D. H. et al. Influenza-induced production of interferon-alpha is defective in geriatric individuals. J. Clin. Immunol. 30, 373\u2013383 (2010).","journal-title":"J. Clin. Immunol."},{"key":"2920_CR300","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1474-9726.2010.00584.x","volume":"9","author":"M Le Garff-Tavernier","year":"2010","unstructured":"Le Garff-Tavernier, M. et al. Human NK cells display major phenotypic and functional changes over the life span. Aging Cell 9, 527\u2013535 (2010).","journal-title":"Aging Cell"},{"key":"2920_CR301","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1365-2567.2007.02573.x","volume":"121","author":"Y Zhang","year":"2007","unstructured":"Zhang, Y. et al. In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infection. Immunology 121, 258\u2013265 (2007).","journal-title":"Immunology"},{"key":"2920_CR302","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41392-022-00899-y","volume":"7","author":"F Fagiani","year":"2022","unstructured":"Fagiani, F. et al. Molecular regulations of circadian rhythm and implications for physiology and diseases. Signal Transduct. Target Ther. 7, 41 (2022).","journal-title":"Signal Transduct. Target Ther."},{"key":"2920_CR303","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20200798","volume":"218","author":"M Palomino-Segura","year":"2021","unstructured":"Palomino-Segura, M. & Hidalgo, A. Circadian immune circuits. J. Exp. Med. 218, e20200798 (2021).","journal-title":"J. Exp. Med."},{"key":"2920_CR304","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.immuni.2019.01.002","volume":"50","author":"JM Adrover","year":"2019","unstructured":"Adrover, J. M. et al. A neutrophil timer coordinates immune defense and vascular protection. Immunity 50, 390\u2013402.e310 (2019).","journal-title":"Immunity"},{"key":"2920_CR305","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1182\/blood-2018-08-867648","volume":"133","author":"A Garc\u00eda-Garc\u00eda","year":"2019","unstructured":"Garc\u00eda-Garc\u00eda, A. et al. Dual cholinergic signals regulate daily migration of hematopoietic stem cells and leukocytes. Blood 133, 224\u2013236 (2019).","journal-title":"Blood"},{"key":"2920_CR306","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41577-018-0008-4","volume":"18","author":"C Scheiermann","year":"2018","unstructured":"Scheiermann, C., Gibbs, J., Ince, L. & Loudon, A. Clocking in to immunity. Nat. Rev. Immunol. 18, 423\u2013437 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"2920_CR307","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nature12209","volume":"498","author":"MT Lam","year":"2013","unstructured":"Lam, M. T. et al. Rev-Erbs repress macrophage gene expression by inhibiting enhancer-directed transcription. Nature 498, 511\u2013515 (2013).","journal-title":"Nature"},{"key":"2920_CR308","doi-asserted-by":"publisher","first-page":"407","DOI":"10.4049\/jimmunol.1301982","volume":"192","author":"S Sato","year":"2014","unstructured":"Sato, S. et al. A circadian clock gene, Rev-erb\u03b1, modulates the inflammatory function of macrophages through the negative regulation of Ccl2 expression. J. Immunol. 192, 407\u2013417 (2014).","journal-title":"J. Immunol."},{"key":"2920_CR309","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.immuni.2006.07.014","volume":"25","author":"R Berland","year":"2006","unstructured":"Berland, R. et al. Toll-like receptor 7-dependent loss of B cell tolerance in pathogenic autoantibody knockin mice. Immunity 25, 429\u2013440 (2006).","journal-title":"Immunity"},{"key":"2920_CR310","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41586-022-04642-z","volume":"605","author":"GJ Brown","year":"2022","unstructured":"Brown, G. J. et al. TLR7 gain-of-function genetic variation causes human lupus. Nature 605, 349\u2013356 (2022).","journal-title":"Nature"},{"key":"2920_CR311","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1182\/blood-2005-07-2650","volume":"107","author":"E Savarese","year":"2006","unstructured":"Savarese, E. et al. U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7. Blood 107, 3229\u20133234 (2006).","journal-title":"Blood"},{"key":"2920_CR312","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/35079114","volume":"411","author":"Y Ogura","year":"2001","unstructured":"Ogura, Y. et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn\u2019s disease. Nature 411, 603\u2013606 (2001).","journal-title":"Nature"},{"key":"2920_CR313","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1053\/gast.2002.32415","volume":"122","author":"AP Cuthbert","year":"2002","unstructured":"Cuthbert, A. P. et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 122, 867\u2013874 (2002).","journal-title":"Gastroenterology"},{"key":"2920_CR314","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1136\/gut.52.11.1591","volume":"52","author":"Y Ogura","year":"2003","unstructured":"Ogura, Y. et al. Expression of NOD2 in Paneth cells: a possible link to Crohn\u2019s ileitis. Gut 52, 1591\u20131597 (2003).","journal-title":"Gut"},{"key":"2920_CR315","doi-asserted-by":"publisher","first-page":"18129","DOI":"10.1073\/pnas.0505256102","volume":"102","author":"J Wehkamp","year":"2005","unstructured":"Wehkamp, J. et al. Reduced Paneth cell \u03b1-defensins in ileal Crohn\u2019s disease. Proc. Natl. Acad. Sci. USA. 102, 18129\u201318134 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2920_CR316","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1038\/mi.2014.19","volume":"7","author":"T Watanabe","year":"2014","unstructured":"Watanabe, T. et al. NOD2 downregulates colonic inflammation by IRF4-mediated inhibition of K63-linked polyubiquitination of RICK and TRAF6. Mucosal Immunol. 7, 1312\u20131325 (2014).","journal-title":"Mucosal Immunol."},{"key":"2920_CR317","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1056\/NEJMoa1312625","volume":"371","author":"Y Liu","year":"2014","unstructured":"Liu, Y. et al. Activated STING in a vascular and pulmonary syndrome. N. Engl. J. Med. 371, 507\u2013518 (2014).","journal-title":"N. Engl. J. Med."},{"key":"2920_CR318","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20232167","volume":"221","author":"E Valeri","year":"2024","unstructured":"Valeri, E. et al. A novel STING variant triggers endothelial toxicity and SAVI disease. J. Exp. Med. 221, e20232167 (2024).","journal-title":"J. Exp. Med."},{"key":"2920_CR319","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.jaip.2020.11.007","volume":"9","author":"ML Fr\u00e9mond","year":"2021","unstructured":"Fr\u00e9mond, M. L. et al. Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) among 21 patients. J. Allergy Clin. Immunol. Pract. 9, 803\u2013818.e811 (2021).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"2920_CR320","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41577-021-00633-9","volume":"22","author":"YJ Crow","year":"2022","unstructured":"Crow, Y. J. & Stetson, D. B. The type I interferonopathies: 10 years on. Nat. Rev. Immunol. 22, 471\u2013483 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"2920_CR321","doi-asserted-by":"publisher","first-page":"101975","DOI":"10.1016\/j.berh.2024.101975","volume":"38","author":"LO Mendon\u00e7a","year":"2024","unstructured":"Mendon\u00e7a, L. O. & Fr\u00e9mond, M.-L. Interferonopathies: from concept to clinical practice. Best Pract. Res. Clin. Rheumatol. 38, 101975 (2024).","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"2920_CR322","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11481-024-10101-5","volume":"19","author":"T Kodi","year":"2024","unstructured":"Kodi, T. et al. New Insights on NLRP3 inflammasome: mechanisms of activation, inhibition, and epigenetic regulation. J. Neuroimmune Pharmacol. 19, 7 (2024).","journal-title":"J. Neuroimmune Pharmacol."},{"key":"2920_CR323","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20231200","volume":"221","author":"C Cosson","year":"2024","unstructured":"Cosson, C. et al. Functional diversity of NLRP3 gain-of-function mutants associated with CAPS autoinflammation. J. Exp. Med. 221, e20231200 (2024).","journal-title":"J. Exp. Med."},{"key":"2920_CR324","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1056\/NEJMoa0810787","volume":"360","author":"J Lachmann Helen","year":"2009","unstructured":"Lachmann Helen, J. et al. Use of canakinumab in the cryopyrin-associated periodic syndrome. N. Engl. J. Med. 360, 2416\u20132425 (2009).","journal-title":"N. Engl. J. Med."},{"key":"2920_CR325","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1136\/annrheumdis-2016-209686","volume":"76","author":"JB Kuemmerle-Deschner","year":"2017","unstructured":"Kuemmerle-Deschner, J. B. et al. Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS). Ann. Rheum. Dis. 76, 942\u2013947 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"2920_CR326","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/ng756","volume":"29","author":"HM Hoffman","year":"2001","unstructured":"Hoffman, H. M. et al. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat. Genet. 29, 301\u2013305 (2001).","journal-title":"Nat. Genet."},{"key":"2920_CR327","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1093\/rheumatology\/ket486","volume":"53","author":"N Alejandre","year":"2014","unstructured":"Alejandre, N. et al. Description of a new family with cryopyrin-associated periodic syndrome: risk of visual loss in patients bearing the R260W mutation. Rheumatology 53, 1095\u20131099 (2014).","journal-title":"Rheumatology"},{"key":"2920_CR328","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10875-019-00638-z","volume":"39","author":"LM Booshehri","year":"2019","unstructured":"Booshehri, L. M. & Hoffman, H. M. CAPS and NLRP3. J. Clin. Immunol. 39, 277\u2013286 (2019).","journal-title":"J. Clin. Immunol."},{"key":"2920_CR329","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1136\/annrheumdis-2013-204991","volume":"74","author":"R Levy","year":"2015","unstructured":"Levy, R. et al. Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry. Ann. Rheum. Dis. 74, 2043\u20132049 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"2920_CR330","doi-asserted-by":"crossref","unstructured":"French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat. Genet. 17, 25\u201331 (1997).","DOI":"10.1038\/ng0997-25"},{"key":"2920_CR331","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/sj.ejhg.5200658","volume":"9","author":"I Touitou","year":"2001","unstructured":"Touitou, I. The spectrum of Familial Mediterranean Fever (FMF) mutations. Eur. J. Hum. Genet. 9, 473\u2013483 (2001).","journal-title":"Eur. J. Hum. Genet."},{"key":"2920_CR332","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/GIM.0b013e3182060456","volume":"13","author":"M Shohat","year":"2011","unstructured":"Shohat, M. & Halpern, G. J. Familial Mediterranean fever\u2014a review. Genet. Med. 13, 487\u2013498 (2011).","journal-title":"Genet. Med."},{"key":"2920_CR333","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41581-018-0107-2","volume":"15","author":"RJH Smith","year":"2019","unstructured":"Smith, R. J. H. et al. C3 glomerulopathy - understanding a rare complement-driven renal disease. Nat. Rev. Nephrol. 15, 129\u2013143 (2019).","journal-title":"Nat. Rev. Nephrol."},{"key":"2920_CR334","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/ki.2012.63","volume":"82","author":"A Servais","year":"2012","unstructured":"Servais, A. et al. Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies. Kidney Int. 82, 454\u2013464 (2012).","journal-title":"Kidney Int."},{"key":"2920_CR335","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/nrneph.2012.213","volume":"8","author":"AS Bomback","year":"2012","unstructured":"Bomback, A. S. & Appel, G. B. Pathogenesis of the C3 glomerulopathies and reclassification of MPGN. Nat. Rev. Nephrol. 8, 634\u2013642 (2012).","journal-title":"Nat. Rev. Nephrol."},{"key":"2920_CR336","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/ki.2012.212","volume":"82","author":"S Sethi","year":"2012","unstructured":"Sethi, S. et al. C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up. Kidney Int. 82, 465\u2013473 (2012).","journal-title":"Kidney Int."},{"key":"2920_CR337","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.ekir.2023.12.007","volume":"9","author":"B Tarragon Estebanez","year":"2024","unstructured":"Tarragon Estebanez, B. & Bomback, A. S. C3 glomerulopathy: novel treatment paradigms. Kidney Int. Rep. 9, 569\u2013579 (2024).","journal-title":"Kidney Int. Rep."},{"key":"2920_CR338","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-2-34","volume":"2","author":"PR Cohen","year":"2007","unstructured":"Cohen, P. R. Sweet\u2019s syndrome\u2014a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J. Rare Dis. 2, 34 (2007).","journal-title":"Orphanet J. Rare Dis."},{"key":"2920_CR339","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41577-022-00787-0","volume":"23","author":"G Wigerblad","year":"2023","unstructured":"Wigerblad, G. & Kaplan, M. J. Neutrophil extracellular traps in systemic autoimmune and autoinflammatory diseases. Nat. Rev. Immunol. 23, 274\u2013288 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"2920_CR340","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1272-8","volume":"10","author":"S Li","year":"2024","unstructured":"Li, S. et al. Neutrophil extracellular traps and neutrophilic dermatosis: an update review. Cell Death Dis. 10, 18 (2024).","journal-title":"Cell Death Dis."},{"key":"2920_CR341","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1056\/NEJMoa1208487","volume":"369","author":"F Lanternier","year":"2013","unstructured":"Lanternier, F. et al. Deep Dermatophytosis and Inherited CARD9 Deficiency. N. Engl. J. Med. 369, 1704\u20131714 (2013).","journal-title":"N. Engl. J. Med."},{"key":"2920_CR342","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/j.jaci.2014.12.1930","volume":"135","author":"F Lanternier","year":"2015","unstructured":"Lanternier, F. et al. Inherited CARD9 deficiency in otherwise healthy children and adults with Candida species-induced meningoencephalitis, colitis, or both. J. Allergy Clin. Immunol. 135, 1558\u20131568.e1552 (2015).","journal-title":"J. Allergy Clin. Immunol."},{"key":"2920_CR343","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/s41590-019-0377-2","volume":"20","author":"RA Drummond","year":"2019","unstructured":"Drummond, R. A. et al. CARD9+ microglia promote antifungal immunity via IL-1\u03b2- and CXCL1-mediated neutrophil recruitment. Nat. Immunol. 20, 559\u2013570 (2019).","journal-title":"Nat. Immunol."},{"key":"2920_CR344","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005293","volume":"11","author":"RA Drummond","year":"2015","unstructured":"Drummond, R. A. et al. CARD9-dependent neutrophil recruitment protects against fungal invasion of the central nervous system. PLoS Pathog. 11, e1005293 (2015).","journal-title":"PLoS Pathog."},{"key":"2920_CR345","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/nature04374","volume":"439","author":"G Oganesyan","year":"2006","unstructured":"Oganesyan, G. et al. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature 439, 208\u2013211 (2006).","journal-title":"Nature"},{"key":"2920_CR346","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.immuni.2010.08.014","volume":"33","author":"R P\u00e9rez de Diego","year":"2010","unstructured":"P\u00e9rez de Diego, R. et al. Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis. Immunity 33, 400\u2013411 (2010).","journal-title":"Immunity"},{"key":"2920_CR347","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abn3800","volume":"7","author":"W Rae","year":"2022","unstructured":"Rae, W. et al. Immunodeficiency, autoimmunity, and increased risk of B-cell malignancy in humans with TRAF3 mutations. Sci. Immunol. 7, eabn3800 (2022).","journal-title":"Sci. Immunol."},{"key":"2920_CR348","doi-asserted-by":"publisher","first-page":"15195","DOI":"10.1074\/jbc.RA118.003314","volume":"293","author":"D De Nardo","year":"2018","unstructured":"De Nardo, D. et al. Interleukin-1 receptor-associated kinase 4 (IRAK4) plays a dual role in myddosome formation and Toll-like receptor signaling. J. Biol. Chem. 293, 15195\u201315207 (2018).","journal-title":"J. Biol. Chem."},{"key":"2920_CR349","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1002\/eji.201242683","volume":"42","author":"H von Bernuth","year":"2012","unstructured":"von Bernuth, H., Picard, C., Puel, A. & Casanova, J. L. Experimental and natural infections in MyD88- and IRAK-4-deficient mice and humans. Eur. J. Immunol. 42, 3126\u20133135 (2012).","journal-title":"Eur. J. Immunol."},{"key":"2920_CR350","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1126\/science.1081902","volume":"299","author":"C Picard","year":"2003","unstructured":"Picard, C. et al. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 299, 2076\u20132079 (2003).","journal-title":"Science"},{"key":"2920_CR351","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1084\/jem.20070628","volume":"204","author":"CL Ku","year":"2007","unstructured":"Ku, C. L. et al. Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J. Exp. Med. 204, 2407\u20132422 (2007).","journal-title":"J. Exp. Med."},{"key":"2920_CR352","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1126\/science.aaa1578","volume":"348","author":"MJ Ciancanelli","year":"2015","unstructured":"Ciancanelli, M. J. et al. Infectious disease. Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency. Science 348, 448\u2013453 (2015).","journal-title":"Science"},{"key":"2920_CR353","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd4570","volume":"370","author":"Q Zhang","year":"2020","unstructured":"Zhang, Q. et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science 370, eabd4570 (2020).","journal-title":"Science"},{"key":"2920_CR354","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20220202","volume":"219","author":"TM Campbell","year":"2022","unstructured":"Campbell, T. M. et al. Respiratory viral infections in otherwise healthy humans with inherited IRF7 deficiency. J. Exp. Med. 219, e20220202 (2022).","journal-title":"J. Exp. Med."},{"key":"2920_CR355","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12016-009-8136-z","volume":"38","author":"SM Holland","year":"2010","unstructured":"Holland, S. M. Chronic granulomatous disease. Clin. Rev. Allergy Immunol. 38, 3\u201310 (2010).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"2920_CR356","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1093\/jpids\/piy008","volume":"7","author":"NL Rider","year":"2018","unstructured":"Rider, N. L., Jameson, M. B. & Creech, C. B. Chronic granulomatous disease: epidemiology, pathophysiology, and genetic basis of disease. J. Pediatr. Infect. Dis. Soc. 7, S2\u2013S5 (2018).","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"2920_CR357","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1164\/rccm.2206007","volume":"166","author":"HJ Forman","year":"2002","unstructured":"Forman, H. J. & Torres, M. Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling. Am. J. Respir. Crit. Care Med. 166, S4\u2013S8 (2002).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2920_CR358","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1007\/s12325-017-0636-2","volume":"34","author":"DE Arnold","year":"2017","unstructured":"Arnold, D. E. & Heimall, J. R. A review of chronic granulomatous disease. Adv. Ther. 34, 2543\u20132557 (2017).","journal-title":"Adv. Ther."},{"key":"2920_CR359","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.jaci.2015.08.017","volume":"137","author":"Y Okura","year":"2016","unstructured":"Okura, Y. et al. Clinical characteristics and genotype-phenotype correlations in C3 deficiency. J. Allergy Clin. Immunol. 137, 640\u2013644.e641 (2016).","journal-title":"J. Allergy Clin. Immunol."},{"key":"2920_CR360","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/BF02722692","volume":"69","author":"M Totan","year":"2002","unstructured":"Totan, M. Recurrent pneumococcal meningitis in homozygous C3 deficiency. Indian J. Pediatr. 69, 625\u2013626 (2002).","journal-title":"Indian J. Pediatr."},{"key":"2920_CR361","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/00006454-199205000-00011","volume":"11","author":"D Peleg","year":"1992","unstructured":"Peleg, D. et al. Inherited C3 deficiency and meningococcal disease in a teenager. Pediatr. Infect. Dis. J. 11, 401\u2013404 (1992).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"2920_CR362","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1128\/CMR.00048-09","volume":"23","author":"S Ram","year":"2010","unstructured":"Ram, S., Lewis, L. A. & Rice, P. A. Infections of people with complement deficiencies and patients who have undergone splenectomy. Clin. Microbiol. Rev. 23, 740\u2013780 (2010).","journal-title":"Clin. Microbiol. Rev."},{"key":"2920_CR363","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1053\/j.seminhematol.2013.06.010","volume":"50","author":"PE Newburger","year":"2013","unstructured":"Newburger, P. E. & Dale, D. C. Evaluation and management of patients with isolated neutropenia. Semin. Hematol. 50, 198\u2013206 (2013).","journal-title":"Semin. Hematol."},{"key":"2920_CR364","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1182\/asheducation-2016.1.38","volume":"2016","author":"PE Newburger","year":"2016","unstructured":"Newburger, P. E. Autoimmune and other acquired neutropenias. Hematol. Am. Soc. Hematol. Educ. Program 2016, 38\u201342 (2016).","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"2920_CR365","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1182\/blood-2013-07-513242","volume":"123","author":"T Tidwell","year":"2014","unstructured":"Tidwell, T. et al. Neutropenia-associated ELANE mutations disrupting translation initiation produce novel neutrophil elastase isoforms. Blood 123, 562\u2013569 (2014).","journal-title":"Blood"},{"key":"2920_CR366","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/ng1940","volume":"39","author":"C Klein","year":"2007","unstructured":"Klein, C. et al. HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat. Genet. 39, 86\u201392 (2007).","journal-title":"Nat. Genet."},{"key":"2920_CR367","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1093\/cid\/cir073","volume":"52","author":"AG Freifeld","year":"2011","unstructured":"Freifeld, A. G. et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 52, e56\u2013e93 (2011).","journal-title":"Clin. Infect. Dis."},{"key":"2920_CR368","doi-asserted-by":"publisher","first-page":"328","DOI":"10.7326\/0003-4819-64-2-328","volume":"64","author":"GP Bodey","year":"1966","unstructured":"Bodey, G. P., Buckley, M., Sathe, Y. S. & Freireich, E. J. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann. Intern. Med. 64, 328\u2013340 (1966).","journal-title":"Ann. Intern. Med."},{"key":"2920_CR369","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.hoc.2012.10.004","volume":"27","author":"MS Horwitz","year":"2013","unstructured":"Horwitz, M. S., Corey, S. J., Grimes, H. L. & Tidwell, T. ELANE mutations in cyclic and severe congenital neutropenia: genetics and pathophysiology. Hematol. Oncol. Clin. North Am. 27, 19\u201341, vii (2013).","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"2920_CR370","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41572-019-0069-0","volume":"5","author":"MA Matthay","year":"2019","unstructured":"Matthay, M. A. et al. Acute respiratory distress syndrome. Nat. Rev. Dis. Primers 5, 18 (2019).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"2920_CR371","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1172\/JCI60331","volume":"122","author":"MA Matthay","year":"2012","unstructured":"Matthay, M. A., Ware, L. B. & Zimmerman, G. A. The acute respiratory distress syndrome. J. Clin. Investig. 122, 2731\u20132740 (2012).","journal-title":"J. Clin. Investig."},{"key":"2920_CR372","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.hlife.2025.09.006","volume":"4","author":"J Li","year":"2026","unstructured":"Li, J. et al. Interplay between bacteria and pulmonary immune system in respiratory infections. hLife 4, 3\u201315 (2026).","journal-title":"hLife"},{"key":"2920_CR373","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/S0140-6736(22)01485-4","volume":"400","author":"LDJ Bos","year":"2022","unstructured":"Bos, L. D. J. & Ware, L. B. Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes. Lancet 400, 1145\u20131156 (2022).","journal-title":"Lancet"},{"key":"2920_CR374","doi-asserted-by":"publisher","first-page":"L165","DOI":"10.1152\/ajplung.00303.2020","volume":"320","author":"MJ McVey","year":"2021","unstructured":"McVey, M. J., Steinberg, B. E. & Goldenberg, N. M. Inflammasome activation in acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 320, L165\u2013l178 (2021).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"2920_CR375","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12931-023-02657-2","volume":"25","author":"MG Detsika","year":"2024","unstructured":"Detsika, M. G. et al. The complement cascade in lung injury and disease. Respir. Res. 25, 20 (2024).","journal-title":"Respir. Res."},{"key":"2920_CR376","doi-asserted-by":"publisher","first-page":"4713","DOI":"10.7150\/ijbs.99456","volume":"20","author":"HX Sha","year":"2024","unstructured":"Sha, H. X. et al. Neutrophil extracellular traps trigger alveolar epithelial cell necroptosis through the cGAS-STING pathway during acute lung injury in mice. Int. J. Biol. Sci. 20, 4713\u20134730 (2024).","journal-title":"Int. J. Biol. Sci."},{"key":"2920_CR377","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.it.2011.04.009","volume":"32","author":"DL Bratton","year":"2011","unstructured":"Bratton, D. L. & Henson, P. M. Neutrophil clearance: when the party is over, clean-up begins. Trends Immunol. 32, 350\u2013357 (2011).","journal-title":"Trends Immunol."},{"key":"2920_CR378","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1165\/rcmb.2023-0426TR","volume":"71","author":"L Song","year":"2024","unstructured":"Song, L., Li, K., Chen, H. & Xie, L. Cell cross-talk in alveolar microenvironment: from lung injury to fibrosis. Am. J. Respir. Cell Mol. Biol. 71, 30\u201342 (2024).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"2920_CR379","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1126\/science.aam6603","volume":"359","author":"AN Nabhan","year":"2018","unstructured":"Nabhan, A. N. et al. Single-cell Wnt signaling niches maintain stemness of alveolar type 2 cells. Science 359, 1118\u20131123 (2018).","journal-title":"Science"},{"key":"2920_CR380","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s12013-021-01012-w","volume":"79","author":"J Nijmeh","year":"2021","unstructured":"Nijmeh, J. & Levy, B. D. Lipid-Derived Mediators are Pivotal to Leukocyte and Lung Cell Responses in Sepsis and ARDS. Cell Biochem. Biophys. 79, 449\u2013459 (2021).","journal-title":"Cell Biochem. Biophys."},{"key":"2920_CR381","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1172\/JCI97943","volume":"128","author":"CN Serhan","year":"2018","unstructured":"Serhan, C. N. & Levy, B. D. Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators. J. Clin. Investig. 128, 2657\u20132669 (2018).","journal-title":"J. Clin. Investig."},{"key":"2920_CR382","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1152\/physrev.00026.2017","volume":"98","author":"N Krishnamoorthy","year":"2018","unstructured":"Krishnamoorthy, N. et al. Specialized proresolving mediators in innate and adaptive immune responses in airway diseases. Physiol. Rev. 98, 1335\u20131370 (2018).","journal-title":"Physiol. Rev."},{"key":"2920_CR383","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.plipres.2010.09.002","volume":"50","author":"M Uddin","year":"2011","unstructured":"Uddin, M. & Levy, B. D. Resolvins: natural agonists for resolution of pulmonary inflammation. Prog. Lipid Res. 50, 75\u201388 (2011).","journal-title":"Prog. Lipid Res."},{"key":"2920_CR384","doi-asserted-by":"publisher","first-page":"982","DOI":"10.4103\/0366-6999.229890","volume":"131","author":"Q Wang","year":"2018","unstructured":"Wang, Q., Yan, S. F., Hao, Y. & Jin, S. W. Specialized pro-resolving mediators regulate alveolar fluid clearance during acute respiratory distress syndrome. Chin. Med. J. 131, 982\u2013989 (2018).","journal-title":"Chin. Med. J."},{"key":"2920_CR385","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nri.2015.4","volume":"16","author":"MC Basil","year":"2016","unstructured":"Basil, M. C. & Levy, B. D. Specialized pro-resolving mediators: endogenous regulators of infection and inflammation. Nat. Rev. Immunol. 16, 51\u201367 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"2920_CR386","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/nrc928","volume":"2","author":"MJ Smyth","year":"2002","unstructured":"Smyth, M. J., Hayakawa, Y., Takeda, K. & Yagita, H. New aspects of natural-killer-cell surveillance and therapy of cancer. Nat. Rev. Cancer 2, 850\u2013861 (2002).","journal-title":"Nat. Rev. Cancer"},{"key":"2920_CR387","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrc3258","volume":"12","author":"K Palucka","year":"2012","unstructured":"Palucka, K. & Banchereau, J. Cancer immunotherapy via dendritic cells. Nat. Rev. Cancer 12, 265\u2013277 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"2920_CR388","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nrd.2018.169","volume":"17","author":"L Cassetta","year":"2018","unstructured":"Cassetta, L. & Pollard, J. W. Targeting macrophages: therapeutic approaches in cancer. Nat. Rev. Drug Discov. 17, 887\u2013904 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2920_CR389","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1083\/jcb.201102147","volume":"196","author":"P Lu","year":"2012","unstructured":"Lu, P., Weaver, V. M. & Werb, Z. The extracellular matrix: a dynamic niche in cancer progression. J. Cell Biol. 196, 395\u2013406 (2012).","journal-title":"J. Cell Biol."},{"key":"2920_CR390","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri, R. The biology and function of fibroblasts in cancer. Nat. Rev. Cancer 16, 582\u2013598 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"2920_CR391","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1084\/jem.20131916","volume":"211","author":"MZ Noman","year":"2014","unstructured":"Noman, M. Z. et al. PD-L1 is a novel direct target of HIF-1\u03b1, and its blockade under hypoxia enhanced MDSC-mediated T cell activation. J. Exp. Med. 211, 781\u2013790 (2014).","journal-title":"J. Exp. Med."},{"key":"2920_CR392","doi-asserted-by":"publisher","first-page":"20212","DOI":"10.1073\/pnas.1320318110","volume":"110","author":"C Feig","year":"2013","unstructured":"Feig, C. et al. Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer. Proc. Natl. Acad. Sci. USA 110, 20212\u201320217 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2920_CR393","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/nm.3541","volume":"20","author":"GT Motz","year":"2014","unstructured":"Motz, G. T. et al. Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors. Nat. Med. 20, 607\u2013615 (2014).","journal-title":"Nat. Med."},{"key":"2920_CR394","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12150","volume":"7","author":"V Bronte","year":"2016","unstructured":"Bronte, V. et al. Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nat. Commun. 7, 12150 (2016).","journal-title":"Nat. Commun."},{"key":"2920_CR395","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/j.cell.2018.10.014","volume":"175","author":"P Andr\u00e9","year":"2018","unstructured":"Andr\u00e9, P. et al. Anti-NKG2A mAb is a checkpoint inhibitor that promotes anti-tumor immunity by unleashing both T and NK cells. Cell 175, 1731\u20131743.e1713 (2018).","journal-title":"Cell"},{"key":"2920_CR396","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s41590-018-0132-0","volume":"19","author":"Q Zhang","year":"2018","unstructured":"Zhang, Q. et al. Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity. Nat. Immunol. 19, 723\u2013732 (2018).","journal-title":"Nat. Immunol."},{"key":"2920_CR397","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1172\/JCI81603","volume":"126","author":"K Weiskopf","year":"2016","unstructured":"Weiskopf, K. et al. CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer. J. Clin. Investig. 126, 2610\u20132620 (2016).","journal-title":"J. Clin. Investig."},{"key":"2920_CR398","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2008.07.001","volume":"134","author":"J Massagu\u00e9","year":"2008","unstructured":"Massagu\u00e9, J. TGFbeta in cancer. Cell 134, 215\u2013230 (2008).","journal-title":"Cell"},{"key":"2920_CR399","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","volume":"24","author":"A Brand","year":"2016","unstructured":"Brand, A. et al. LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells. Cell Metab. 24, 657\u2013671 (2016).","journal-title":"Cell Metab."},{"key":"2920_CR400","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1172\/JCI31178","volume":"117","author":"DH Munn","year":"2007","unstructured":"Munn, D. H. & Mellor, A. L. Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J. Clin. Investig. 117, 1147\u20131154 (2007).","journal-title":"J. Clin. Investig."},{"key":"2920_CR401","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","volume":"14","author":"A Mantovani","year":"2017","unstructured":"Mantovani, A. et al. Tumour-associated macrophages as treatment targets in oncology. Nat. Rev. Clin. Oncol. 14, 399\u2013416 (2017).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2920_CR402","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cmet.2019.06.001","volume":"30","author":"I Vitale","year":"2019","unstructured":"Vitale, I. et al. Macrophages and metabolism in the tumor microenvironment. Cell Metab. 30, 36\u201350 (2019).","journal-title":"Cell Metab."},{"key":"2920_CR403","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","volume":"141","author":"BZ Qian","year":"2010","unstructured":"Qian, B. Z. & Pollard, J. W. Macrophage diversity enhances tumor progression and metastasis. Cell 141, 39\u201351 (2010).","journal-title":"Cell"},{"key":"2920_CR404","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41577-020-00490-y","volume":"21","author":"F Veglia","year":"2021","unstructured":"Veglia, F., Sanseviero, E. & Gabrilovich, D. I. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity. Nat. Rev. Immunol. 21, 485\u2013498 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"2920_CR405","doi-asserted-by":"publisher","first-page":"5944","DOI":"10.1038\/onc.2008.272","volume":"27","author":"N Nausch","year":"2008","unstructured":"Nausch, N. & Cerwenka, A. NKG2D ligands in tumor immunity. Oncogene 27, 5944\u20135958 (2008).","journal-title":"Oncogene"},{"key":"2920_CR406","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41392-021-00670-9","volume":"6","author":"K Li","year":"2021","unstructured":"Li, K. et al. Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer. Signal Transduct. Target Ther. 6, 362 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"2920_CR407","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1172\/JCI80005","volume":"125","author":"D Marvel","year":"2015","unstructured":"Marvel, D. & Gabrilovich, D. I. Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected. J. Clin. Investig. 125, 3356\u20133364 (2015).","journal-title":"J. Clin. Investig."},{"key":"2920_CR408","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/s41569-021-00668-4","volume":"19","author":"SE Engelen","year":"2022","unstructured":"Engelen, S. E., Robinson, A. J. B., Zurke, Y.-X. & Monaco, C. Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed? Nat. Rev. Cardiol. 19, 522\u2013542 (2022).","journal-title":"Nat. Rev. Cardiol."},{"key":"2920_CR409","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41577-021-00584-1","volume":"22","author":"P Roy","year":"2022","unstructured":"Roy, P., Orecchioni, M. & Ley, K. How the immune system shapes atherosclerosis: roles of innate and adaptive immunity. Nat. Rev. Immunol. 22, 251\u2013265 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"2920_CR410","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1172\/JCI1112","volume":"101","author":"VA Fadok","year":"1998","unstructured":"Fadok, V. A. et al. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine\/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Investig. 101, 890\u2013898 (1998).","journal-title":"J. Clin. Investig."},{"key":"2920_CR411","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1161\/01.ATV.0000229218.97976.43","volume":"26","author":"KJ Moore","year":"2006","unstructured":"Moore, K. J. & Freeman, M. W. Scavenger receptors in atherosclerosis: beyond lipid uptake. Arterioscler. Thromb. Vasc. Biol. 26, 1702\u20131711 (2006).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2920_CR412","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1161\/01.ATV.0000166517.18801.a7","volume":"25","author":"DM Schrijvers","year":"2005","unstructured":"Schrijvers, D. M. et al. Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 25, 1256\u20131261 (2005).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2920_CR413","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1161\/CIRCULATIONAHA.116.025684","volume":"135","author":"Y Kojima","year":"2017","unstructured":"Kojima, Y., Weissman, I. L. & Leeper, N. J. The role of efferocytosis in atherosclerosis. Circulation 135, 476\u2013489 (2017).","journal-title":"Circulation"},{"key":"2920_CR414","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","volume":"5","author":"P Libby","year":"2019","unstructured":"Libby, P. et al. Atherosclerosis. Nat. Rev. Dis. Primers 5, 56 (2019).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"2920_CR415","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1161\/01.CIR.99.3.348","volume":"99","author":"Z Mallat","year":"1999","unstructured":"Mallat, Z. et al. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 99, 348\u2013353 (1999).","journal-title":"Circulation"},{"key":"2920_CR416","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00395-011-0192-x","volume":"106","author":"W Martinet","year":"2011","unstructured":"Martinet, W., Schrijvers, D. M. & De Meyer, G. R. Necrotic cell death in atherosclerosis. Basic Res. Cardiol. 106, 749\u2013760 (2011).","journal-title":"Basic Res. Cardiol."},{"key":"2920_CR417","doi-asserted-by":"publisher","first-page":"4937","DOI":"10.1158\/1078-0432.CCR-17-1866","volume":"24","author":"C Kyi","year":"2018","unstructured":"Kyi, C. et al. Therapeutic immune modulation against solid cancers with intratumoral poly-ICLC: a pilot trial. Clin. Cancer Res. 24, 4937\u20134948 (2018).","journal-title":"Clin. Cancer Res."},{"key":"2920_CR418","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.jhep.2017.10.027","volume":"68","author":"HLA Janssen","year":"2018","unstructured":"Janssen, H. L. A. et al. Safety, efficacy and pharmacodynamics of vesatolimod (GS-9620) in virally suppressed patients with chronic hepatitis B. J. Hepatol. 68, 431\u2013440 (2018).","journal-title":"J. Hepatol."},{"key":"2920_CR419","doi-asserted-by":"publisher","first-page":"R155","DOI":"10.1186\/ar3895","volume":"14","author":"K Sacre","year":"2012","unstructured":"Sacre, K., Criswell, L. A. & McCune, J. M. Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus. Arthritis Res. Ther. 14, R155 (2012).","journal-title":"Arthritis Res. Ther."},{"key":"2920_CR420","doi-asserted-by":"publisher","first-page":"85","DOI":"10.18773\/austprescr.2020.022","volume":"43","author":"KP McKeon","year":"2020","unstructured":"McKeon, K. P. & Jiang, S. H. Treatment of systemic lupus erythematosus. Aust. Prescr. 43, 85\u201390 (2020).","journal-title":"Aust. Prescr."},{"key":"2920_CR421","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.70059","volume":"7","author":"F Hosein","year":"2025","unstructured":"Hosein, F. et al. Safety, tolerability, efficacy, pharmacokinetics, and pharmacodynamics of afimetoran, a toll-like receptor 7 and 8 inhibitor, in patients with Cutaneous Lupus Erythematosus: a phase 1b randomized, double-blind, placebo-controlled study. ACR Open Rheumatol. 7, e70059 (2025).","journal-title":"ACR Open Rheumatol."},{"key":"2920_CR422","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1002\/cpt.3216","volume":"115","author":"L Klopp-Schulze","year":"2024","unstructured":"Klopp-Schulze, L. et al. Asia-inclusive global development of enpatoran: results of an ethno-bridging study, intrinsic\/extrinsic factor assessments and disease trajectory modeling to inform design of a phase II multiregional clinical trial. Clin. Pharmacol. Ther. 115, 1346\u20131357 (2024).","journal-title":"Clin. Pharmacol. Ther."},{"key":"2920_CR423","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/s13075-019-2008-6","volume":"21","author":"SI Danto","year":"2019","unstructured":"Danto, S. I. et al. Safety, tolerability, pharmacokinetics, and pharmacodynamics of PF-06650833, a selective interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitor, in single and multiple ascending dose randomized phase 1 studies in healthy subjects. Arthritis Res. Ther. 21, 269 (2019).","journal-title":"Arthritis Res. Ther."},{"key":"2920_CR424","doi-asserted-by":"publisher","first-page":"18022","DOI":"10.1021\/acs.jmedchem.4c01305","volume":"67","author":"X Zheng","year":"2024","unstructured":"Zheng, X. et al. Discovery of KT-474\u2500a potent, selective, and orally bioavailable IRAK4 degrader for the treatment of autoimmune diseases. J. Med. Chem. 67, 18022\u201318037 (2024).","journal-title":"J. Med. Chem."},{"key":"2920_CR425","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1158\/1078-0432.CCR-22-2235","volume":"29","author":"F Meric-Bernstam","year":"2023","unstructured":"Meric-Bernstam, F. et al. Combination of the STING agonist MIW815 (ADU-S100) and PD-1 inhibitor spartalizumab in advanced\/metastatic solid tumors or lymphomas: an open-label, multicenter, phase Ib study. Clin. Cancer Res. 29, 110\u2013121 (2023).","journal-title":"Clin. Cancer Res."},{"key":"2920_CR426","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s11912-023-01361-0","volume":"25","author":"JB Hines","year":"2023","unstructured":"Hines, J. B., Kacew, A. J. & Sweis, R. F. The development of STING agonists and emerging results as a cancer immunotherapy. Curr. Oncol. Rep. 25, 189\u2013199 (2023).","journal-title":"Curr. Oncol. Rep."},{"key":"2920_CR427","doi-asserted-by":"publisher","first-page":"e010511","DOI":"10.1136\/jitc-2024-010511","volume":"13","author":"JL Jason","year":"2025","unstructured":"Jason, J. L. et al. Phase I dose-escalation and pharmacodynamic study of STING agonist E7766 in advanced solid tumors. J. ImmunoTher. Cancer 13, e010511 (2025).","journal-title":"J. ImmunoTher. Cancer"},{"key":"2920_CR428","doi-asserted-by":"publisher","first-page":"1485546","DOI":"10.3389\/fimmu.2024.1485546","volume":"15","author":"B Wang","year":"2024","unstructured":"Wang, B. et al. Clinical applications of STING agonists in cancer immunotherapy: current progress and future prospects. Front. Immunol. 15, 1485546 (2024).","journal-title":"Front. Immunol."},{"key":"2920_CR429","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/med.20097","volume":"28","author":"B Bhattacharyya","year":"2008","unstructured":"Bhattacharyya, B., Panda, D., Gupta, S. & Banerjee, M. Anti-mitotic activity of colchicine and the structural basis for its interaction with tubulin. Med. Res. Rev. 28, 155\u2013183 (2008).","journal-title":"Med. Res. Rev."},{"key":"2920_CR430","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1016\/S2665-9913(20)30065-5","volume":"2","author":"V Kl\u00fcck","year":"2020","unstructured":"Kl\u00fcck, V. et al. Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial. Lancet Rheumatol. 2, e270\u2013e280 (2020).","journal-title":"Lancet Rheumatol."},{"key":"2920_CR431","doi-asserted-by":"publisher","first-page":"14897","DOI":"10.1021\/acs.jmedchem.3c01398","volume":"66","author":"D Harrison","year":"2023","unstructured":"Harrison, D. et al. Discovery of clinical candidate NT-0796, a brain-penetrant and highly potent NLRP3 inflammasome inhibitor for neuroinflammatory disorders. J. Med. Chem. 66, 14897\u201314911 (2023).","journal-title":"J. Med. Chem."},{"key":"2920_CR432","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/cpdd.1162","volume":"12","author":"DV Parmar","year":"2023","unstructured":"Parmar, D. V. et al. Safety, tolerability, pharmacokinetics, and pharmacodynamics of the oral NLRP3 inflammasome inhibitor ZYIL1: first-in-human phase 1 studies (single ascending dose and multiple ascending dose). Clin. Pharmacol. Drug Dev. 12, 202\u2013211 (2023).","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"2920_CR433","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1007\/s10787-024-01508-w","volume":"32","author":"ME Kamal","year":"2024","unstructured":"Kamal, M. E. et al. Efficacy and safety of infliximab and adalimumab in inflammatory bowel disease patients. Inflammopharmacology 32, 3259\u20133269 (2024).","journal-title":"Inflammopharmacology"},{"key":"2920_CR434","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s40744-021-00418-5","volume":"9","author":"E Feist","year":"2022","unstructured":"Feist, E. et al. Effectiveness of etanercept in rheumatoid arthritis: real-world data from the German non-interventional study adequate with focus on treat-to-target and patient-reported outcomes. Rheumatol. Ther. 9, 621\u2013635 (2022).","journal-title":"Rheumatol. Ther."},{"key":"2920_CR435","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2147\/JIR.S206204","volume":"13","author":"M Kacar","year":"2020","unstructured":"Kacar, M., Savic, S. & van der Hilst, J. C. H. The efficacy, safety and tolerability of canakinumab in the treatment of familial mediterranean fever: a systematic review of the literature. J. Inflamm. Res. 13, 141\u2013149 (2020).","journal-title":"J. Inflamm. Res."},{"key":"2920_CR436","doi-asserted-by":"publisher","first-page":"3939","DOI":"10.2147\/DDDT.S261119","volume":"18","author":"PK Vlachakis","year":"2024","unstructured":"Vlachakis, P. K. et al. Clinical utility of rilonacept for the treatment of recurrent pericarditis: design, development, and place in therapy. Drug Des. Dev. Ther. 18, 3939\u20133950 (2024).","journal-title":"Drug Des. Dev. Ther."},{"key":"2920_CR437","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1016\/j.clinthera.2004.12.019","volume":"26","author":"DE Furst","year":"2004","unstructured":"Furst, D. E. Anakinra: Review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritis. Clin. Ther. 26, 1960\u20131975 (2004).","journal-title":"Clin. Ther."},{"key":"2920_CR438","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1002\/art.41699","volume":"73","author":"KG Saag","year":"2021","unstructured":"Saag, K. G. et al. A randomized, phase II study evaluating the efficacy and safety of anakinra in the treatment of gout flares. Arthritis Rheumatol. 73, 1533\u20131542 (2021).","journal-title":"Arthritis Rheumatol."},{"key":"2920_CR439","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1177\/2040620716653745","volume":"7","author":"S Sarosiek","year":"2016","unstructured":"Sarosiek, S., Shah, R. & Munshi, N. C. Review of siltuximab in the treatment of multicentric Castleman\u2019s disease. Ther. Adv. Hematol. 7, 360\u2013366 (2016).","journal-title":"Ther. Adv. Hematol."},{"key":"2920_CR440","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s40744-018-0102-x","volume":"5","author":"A Rubbert-Roth","year":"2018","unstructured":"Rubbert-Roth, A. et al. A review of recent advances using tocilizumab in the treatment of rheumatic diseases. Rheumatol. Ther. 5, 21\u201342 (2018).","journal-title":"Rheumatol. Ther."},{"key":"2920_CR441","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/S1474-4422(20)30078-8","volume":"19","author":"A Traboulsee","year":"2020","unstructured":"Traboulsee, A. et al. Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial. Lancet Neurol. 19, 402\u2013412 (2020).","journal-title":"Lancet Neurol."},{"key":"2920_CR442","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s40263-021-00822-z","volume":"35","author":"SL Cohan","year":"2021","unstructured":"Cohan, S. L. et al. Interferons and Multiple Sclerosis: lessons from 25 years of clinical and real-world experience with intramuscular interferon beta-1a (Avonex). CNS Drugs 35, 743\u2013767 (2021).","journal-title":"CNS Drugs"},{"key":"2920_CR443","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2165\/00003495-199243010-00008","volume":"43","author":"PA Todd","year":"1992","unstructured":"Todd, P. A. & Goa, K. L. Interferon gamma-1b. Drugs 43, 111\u2013122 (1992).","journal-title":"Drugs"},{"key":"2920_CR444","doi-asserted-by":"publisher","first-page":"407","DOI":"10.5114\/reum.2020.102006","volume":"58","author":"I Urits","year":"2020","unstructured":"Urits, I. et al. Baricitinib for the treatment of rheumatoid arthritis. Reumatologia 58, 407\u2013415 (2020).","journal-title":"Reumatologia"},{"key":"2920_CR445","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1056\/NEJMoa1110556","volume":"366","author":"C Harrison","year":"2012","unstructured":"Harrison, C. et al. JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis. N. Engl. J. Med. 366, 787\u2013798 (2012).","journal-title":"N. Engl. J. Med."},{"key":"2920_CR446","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1177\/1091581817740873","volume":"36","author":"JA Lansita","year":"2017","unstructured":"Lansita, J. A. et al. Nonclinical development of ANX005: a humanized anti-C1q antibody for treatment of autoimmune and neurodegenerative diseases. Int. J. Toxicol. 36, 449\u2013462 (2017).","journal-title":"Int. J. Toxicol."},{"key":"2920_CR447","doi-asserted-by":"publisher","DOI":"10.1111\/jns.70009","volume":"30","author":"QD Mohammad","year":"2025","unstructured":"Mohammad, Q. D. et al. Results from a phase 1 study evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of ANX005, a C1q inhibitor, in patients with Guillain-Barr\u00e9 syndrome. J. Peripher. Nerv. Syst. 30, e70009 (2025).","journal-title":"J. Peripher. Nerv. Syst."},{"key":"2920_CR448","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1056\/NEJMoa2027760","volume":"384","author":"A R\u00f6th","year":"2021","unstructured":"R\u00f6th, A. et al. Sutimlimab in cold agglutinin disease. N. Engl. J. Med. 384, 1323\u20131334 (2021).","journal-title":"N. Engl. J. Med."},{"key":"2920_CR449","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1182\/blood.2021014955","volume":"140","author":"A R\u00f6th","year":"2022","unstructured":"R\u00f6th, A. et al. Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial. Blood 140, 980\u2013991 (2022).","journal-title":"Blood"},{"key":"2920_CR450","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.clim.2004.05.007","volume":"114","author":"AE Davis","year":"2005","unstructured":"Davis, A. E. 3rd. The pathophysiology of hereditary angioedema. Clin. Immunol. 114, 3\u20139 (2005).","journal-title":"Clin. Immunol."},{"key":"2920_CR451","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1056\/NEJMoa0805538","volume":"363","author":"L Zuraw Bruce","year":"2010","unstructured":"Zuraw Bruce, L. et al. Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema. N. Engl. J. Med. 363, 513\u2013522 (2010).","journal-title":"N. Engl. J. Med."},{"key":"2920_CR452","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/S0140-6736(23)01520-9","volume":"402","author":"JS Heier","year":"2023","unstructured":"Heier, J. S. et al. Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials. Lancet 402, 1434\u20131448 (2023).","journal-title":"Lancet"},{"key":"2920_CR453","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1056\/NEJMoa2029073","volume":"384","author":"P Hillmen","year":"2021","unstructured":"Hillmen, P. et al. Pegcetacoplan versus eculizumab in paroxysmal nocturnal hemoglobinuria. N. Engl. J. Med. 384, 1028\u20131037 (2021).","journal-title":"N. Engl. J. Med."},{"key":"2920_CR454","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1056\/NEJMoa061648","volume":"355","author":"P Hillmen","year":"2006","unstructured":"Hillmen, P. et al. The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N. Engl. J. Med. 355, 1233\u20131243 (2006).","journal-title":"N. Engl. J. Med."},{"key":"2920_CR455","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","volume":"368","author":"CM Legendre","year":"2013","unstructured":"Legendre, C. M. et al. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N. Engl. J. Med. 368, 2169\u20132181 (2013).","journal-title":"N. Engl. J. Med."},{"key":"2920_CR456","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/S1474-4422(17)30369-1","volume":"16","author":"JF Howard Jr","year":"2017","unstructured":"Howard, J. F. Jr et al. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study. Lancet Neurol. 16, 976\u2013986 (2017).","journal-title":"Lancet Neurol."},{"key":"2920_CR457","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1056\/NEJMoa1900866","volume":"381","author":"SJ Pittock","year":"2019","unstructured":"Pittock, S. J. et al. Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder. N. Engl. J. Med. 381, 614\u2013625 (2019).","journal-title":"N. Engl. J. Med."},{"key":"2920_CR458","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1182\/blood-2018-09-876136","volume":"133","author":"JW Lee","year":"2019","unstructured":"Lee, J. W. et al. Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study. Blood 133, 530\u2013539 (2019).","journal-title":"Blood"},{"key":"2920_CR459","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1681\/ASN.2016111179","volume":"28","author":"DRW Jayne","year":"2017","unstructured":"Jayne, D. R. W. et al. Randomized trial of C5a receptor inhibitor avacopan in ANCA-associated vasculitis. J. Am. Soc. Nephrol. 28, 2756\u20132767 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"2920_CR460","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/S2213-2600(22)00297-1","volume":"10","author":"APJ Vlaar","year":"2022","unstructured":"Vlaar, A. P. J. et al. Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial. Lancet Respir. Med. 10, 1137\u20131146 (2022).","journal-title":"Lancet Respir. Med."},{"key":"2920_CR461","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1164\/rccm.201405-0992OC","volume":"191","author":"SI Rennard","year":"2015","unstructured":"Rennard, S. I. et al. CXCR2 antagonist MK-7123. A phase 2 proof-of-concept trial for chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 191, 1001\u20131011 (2015).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2920_CR462","doi-asserted-by":"publisher","first-page":"108257","DOI":"10.1016\/j.pharmthera.2022.108257","volume":"237","author":"K Dhayni","year":"2022","unstructured":"Dhayni, K. et al. Targeting CXCR1 and CXCR2 receptors in cardiovascular diseases. Pharmacol. Ther. 237, 108257 (2022).","journal-title":"Pharmacol. Ther."},{"key":"2920_CR463","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.pupt.2011.03.001","volume":"24","author":"N Aikawa","year":"2011","unstructured":"Aikawa, N. et al. Reevaluation of the efficacy and safety of the neutrophil elastase inhibitor, Sivelestat, for the treatment of acute lung injury associated with systemic inflammatory response syndrome; a phase IV study. Pulm. Pharmacol. Ther. 24, 549\u2013554 (2011).","journal-title":"Pulm. Pharmacol. Ther."},{"key":"2920_CR464","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1056\/NEJMoa1411366","volume":"373","author":"WD Tap","year":"2015","unstructured":"Tap, W. D. et al. Structure-guided blockade of CSF1R kinase in tenosynovial giant-cell tumor. N. Engl. J. Med. 373, 428\u2013437 (2015).","journal-title":"N. Engl. J. Med."},{"key":"2920_CR465","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1016\/S0140-6736(24)00885-7","volume":"403","author":"H Gelderblom","year":"2024","unstructured":"Gelderblom, H. et al. Vimseltinib versus placebo for tenosynovial giant cell tumour (MOTION): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 403, 2709\u20132719 (2024).","journal-title":"Lancet"},{"key":"2920_CR466","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nature19834","volume":"539","author":"MM Kaneda","year":"2016","unstructured":"Kaneda, M. M. et al. PI3K\u03b3 is a molecular switch that controls immune suppression. Nature 539, 437\u2013442 (2016).","journal-title":"Nature"},{"key":"2920_CR467","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20210582","volume":"218","author":"AJ Wilk","year":"2021","unstructured":"Wilk, A. J. et al. Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19. J. Exp. Med. 218, e20210582 (2021).","journal-title":"J. Exp. Med."},{"key":"2920_CR468","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1158\/1078-0432.CCR-22-3313","volume":"29","author":"DS Hong","year":"2023","unstructured":"Hong, D. S. et al. Eganelisib, a first-in-class PI3K\u03b3 inhibitor, in patients with advanced solid tumors: results of the phase 1\/1b MARIO-1 trial. Clin. Cancer Res. 29, 2210\u20132219 (2023).","journal-title":"Clin. Cancer Res."},{"key":"2920_CR469","doi-asserted-by":"publisher","first-page":"1007081","DOI":"10.3389\/fmicb.2022.1007081","volume":"13","author":"EA Halajian","year":"2022","unstructured":"Halajian, E. A., LeBlanc, E. V., Gee, K. & Colpitts, C. C. Activation of TLR4 by viral glycoproteins: a double-edged sword? Front. Microbiol. 13, 1007081 (2022).","journal-title":"Front. Microbiol."},{"key":"2920_CR470","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/j.1462-5822.2009.01294.x","volume":"11","author":"SC Corr","year":"2009","unstructured":"Corr, S. C. & O\u2019Neill, L. A. J. Listeria monocytogenes infection in the face of innate immunity. Cell. Microbiol. 11, 703\u2013709 (2009).","journal-title":"Cell. Microbiol."},{"key":"2920_CR471","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02347-19","volume":"10","author":"F Cottier","year":"2019","unstructured":"Cottier, F. et al. Remasking of Candida albicans \u03b2-glucan in response to environmental pH is regulated by quorum sensing. mBio. 10, e02347-19 (2019).","journal-title":"mBio."},{"key":"2920_CR472","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/febs.13389","volume":"283","author":"AL Garfoot","year":"2016","unstructured":"Garfoot, A. L. & Rappleye, C. A. Histoplasma capsulatum surmounts obstacles to intracellular pathogenesis. FEBS J. 283, 619\u2013633 (2016).","journal-title":"FEBS J."},{"key":"2920_CR473","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41564-018-0322-4","volume":"4","author":"K Zhao","year":"2019","unstructured":"Zhao, K. et al. TesG is a type I secretion effector of Pseudomonas aeruginosa that suppresses the host immune response during chronic infection. Nat. Microbiol. 4, 459\u2013469 (2019).","journal-title":"Nat. Microbiol."},{"key":"2920_CR474","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s41564-025-02233-y","volume":"11","author":"Y Gao","year":"2026","unstructured":"Gao, Y. et al. Fungal commensal promotes intestinal repair via its secreted peptide in mice. Nat. Microbiol. 11, 476\u2013491 (2026).","journal-title":"Nat. Microbiol."},{"key":"2920_CR475","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41579-025-01183-w","volume":"23","author":"I Mukhopadhya","year":"2025","unstructured":"Mukhopadhya, I. & Louis, P. Gut microbiota-derived short-chain fatty acids and their role in human health and disease. Nat. Rev. Microbiol. 23, 635\u2013651 (2025).","journal-title":"Nat. Rev. Microbiol."},{"key":"2920_CR476","doi-asserted-by":"publisher","DOI":"10.34133\/research.0007","volume":"2022","author":"DH Kim","year":"2022","unstructured":"Kim, D. H. et al. Lactobacillus salivarius HHuMin-U activates innate immune defense against norovirus infection through TBK1-IRF3 and NF-\u03baB signaling pathways. Research 2022, 0007 (2022).","journal-title":"Research"},{"key":"2920_CR477","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.45","volume":"2","author":"RS Hotchkiss","year":"2016","unstructured":"Hotchkiss, R. S. et al. Sepsis and septic shock. Nat. Rev. Dis. Primers 2, 16045 (2016).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"2920_CR478","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1111\/jth.15852","volume":"20","author":"T Iba","year":"2022","unstructured":"Iba, T., Levi, M. & Levy, J. H. Intracellular communication and immunothrombosis in sepsis. J. Thromb. Haemost. 20, 2475\u20132484 (2022).","journal-title":"J. Thromb. Haemost."},{"key":"2920_CR479","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41591-023-02673-1","volume":"30","author":"R Sankowski","year":"2024","unstructured":"Sankowski, R. et al. Multiomic spatial landscape of innate immune cells at human central nervous system borders. Nat. Med. 30, 186\u2013198 (2024).","journal-title":"Nat. Med."},{"key":"2920_CR480","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41586-024-07791-5","volume":"633","author":"T Recaldin","year":"2024","unstructured":"Recaldin, T. et al. Human organoids with an autologous tissue-resident immune compartment. Nature 633, 165\u2013173 (2024).","journal-title":"Nature"},{"key":"2920_CR481","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41422-025-01171-y","volume":"35","author":"T Schl\u00fcter","year":"2025","unstructured":"Schl\u00fcter, T. et al. Trained immunity: induction of an inflammatory memory in disease. Cell Res. 35, 792\u2013802 (2025).","journal-title":"Cell Res."},{"key":"2920_CR482","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/s41591-023-02785-8","volume":"30","author":"D Marin","year":"2024","unstructured":"Marin, D. et al. Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1\/2 trial. Nat. Med. 30, 772\u2013784 (2024).","journal-title":"Nat. Med."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02920-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02920-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02920-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:01:27Z","timestamp":1786492887000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02920-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":482,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2920"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02920-0","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"assertion":[{"value":"8 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"321"}}